Document:

tenx_ex101

Exhibit 10.1

 

EXECUTIVE EMPLOYMENT AGREEMENT

 

THIS EXECUTIVE EMPLOYMENT AGREEMENT
(this “Agreement”), is made as of the
Effective Date (as defined below) by and between Tenax
Therapeutics, Inc., a Delaware corporation, with its principal
place of business in North Carolina (the “Company”), and Stuart Rich, MD
(the “Executive”).

 

W I T N E S S E T H:

 

WHEREAS, the Executive was formerly an
owner and founder of PH Precision Med. (“PHPM”);

 

WHEREAS, the Company is entering into
that certain Agreement and Plan of Merger (the “Transaction Agreement”) with PHPM
through which the Company will enter into a merger agreement with
PHPM (the “Transaction”);

 

WHEREAS, in connection with the
Transaction, the Company desires to employ the Executive as its
Chief Medical Officer and provide adequate assurances to the
Executive and the Executive desires to accept such employment on
the terms set forth below;

 

WHEREAS, this Agreement is conditioned
upon the closing of the Transaction, and in the event the
Transaction does not close, this Agreement shall be void ab initio and of no
effect;

 

WHEREAS, the terms of this Agreement
supersede and replace any prior agreements, representations,
arrangements or understandings (whether written, oral, implied or
otherwise) between the Executive and the Company or PHPM regarding
the subject matter set forth herein; provided that the Transaction
Agreement is expressly preserved; and

 

WHEREAS, this Agreement shall be
effective as of the Closing Date of the Merger (as defined in the
Transaction Agreement) (the “Effective Date”).

 

NOW, THEREFORE, in consideration of the
foregoing, of the mutual promises herein, and of other good and
valuable consideration, the receipt and sufficiency of which the
parties acknowledge, the Company and the Executive agree as
follows:

 

1. Employment. Effective as of the
Effective Date, the
Company hereby employs the Executive and the Executive hereby
accepts employment as Chief Medical Officer of the Company upon the
terms and conditions of this Agreement. The position is a remote
position.

 

2. Duties. The Executive will have
such authority, and will faithfully perform all of the duties,
normally associated with the position of Chief Medical Officer,
including but not limited to all duties set forth in this
Agreement, and all additional duties consistent with such position
that are reasonably prescribed from time to time by the Chief
Executive Officer of the Company. The Executive shall devote such
business time and attention as reasonably necessary to perform his
duties and responsibilities on behalf of the Company and in
furtherance of its best interests; provided, however, that he,
subject to his obligations hereunder, shall be permitted to make
personal investments, perform reasonable volunteer services, serve
on the board of one or more charitable organizations, and serve on
the board of one for profit, publicly traded company so long as it
is not in competition with the Company. The Executive shall comply
with all Company policies, standards, rules and regulations (the
“Company Policies”) as may exist from
time-to-time and all applicable government laws, rules and
regulations that are now or hereafter in effect.

 

 

 

 

3. Term. Unless earlier terminated
as provided herein, the initial term of this Agreement shall
commence on the Effective Date and shall continue until the one-year
anniversary of the Effective Date (the “Initial Term”). After the Initial
Term, this Agreement shall automatically renew for successive
one-year terms on the same terms and conditions set forth herein
unless: (a) earlier terminated or amended as provided herein; or
(b) either party gives the other written notice of non-renewal at
least ninety (90) days prior to the end of the Initial Term or any
renewal term of this Agreement, in which case, this Agreement shall
terminate on the expiration of the then-current Term. The Initial
Term of this Agreement and all applicable renewals thereof are
referred to herein as the “Term.”

 

4. Compensation. During the Term,
as compensation for the services rendered by the Executive under
this Agreement, the Executive shall be entitled to receive the
following (all payments are subject to applicable
withholdings):

(a) Base
Salary. The Executive shall receive an annual salary of
Three Hundred Thousand Dollars and 00/100 Dollars ($300,000.00)
(less applicable withholdings) (“Base Salary”) payable
in accordance with the payroll policies of the Company as set forth
in the Company Policies. The Chief Executive Officer of the Company
shall review, on an annual basis, the Executive’s salary and
may increase or decrease such salary as the Chief Executive Officer
deems appropriate; provided, however, that any decrease shall only
be effective if it is a result of an across-the-board decrease
affecting all senior executives as a group.

 

(b) Bonuses. Each fiscal year
during the Term, the Executive shall be entitled to an annual bonus
the amount of which is based on percentage achievement of annual
goals set by the Company, after consultation with the Executive, at
the beginning of each fiscal year for such fiscal year
(“Annual
Bonus”), which achievement shall be determined as of
the last day of such fiscal year. If the Executive achieves one
hundred percent (100%) of the annual goals, the Annual Bonus shall
be forty percent (40%) of his Base Salary (“Target Bonus”). There is no cap on
the Annual Bonus for exceeding one hundred percent (100%) of annual
goals; for example, an achievement of two hundred percent (200%) of
annual goals would result in an Annual Bonus equal to eighty
percent (80%) of his Base Salary. The Annual Bonus shall be paid in
accordance with the Company’s regular bonus payment
procedures, and, in all events, will be paid no later than
seventy-five (75) days following the end of the fiscal year in
which the Annual Bonus was earned. Except as otherwise set forth in
Section 5(d)(ii)(C), in order to be eligible to receive the Annual
Bonus, the Executive must be employed by the Company on the last
day of the fiscal year in which the Annual Bonus was
earned.

 

(c) Benefits. The Executive shall
be entitled to receive those benefits provided from time to time to
other executive employees of the Company, in accordance with the terms and
conditions of the applicable plan documents, provided that the
Executive meets the eligibility requirements thereof. All such
benefits are subject to amendment or termination from time to time
by the Company without the consent of the Executive or any other
employee of the Company.

 

 

 

 

(d) Business Expenses. The Company
shall pay, or reimburse the Executive for, all reasonable expenses
incurred by the Executive directly related to conduct of the
business of the Company; provided that the Executive complies with
the Company’s Policies for the reimbursement or advancement
of business expenses that are now or hereafter in effect. The
Company shall provide such payments or reimbursements within thirty
(30) days following the Executive’s incurrence of the
expense.

 

(e) Option Award. The Board of
Directors of the Company (the “Board”) has approved a
nonstatutory stock option entitling the Executive to purchase up to
250,000 shares of Company Common Stock (the “Option”) at the fair market value
as of the date of grant as determined by the Board in its sole
discretion. The terms and conditions, including vesting, for the
Option will be set forth in a Nonstatutory Stock Option Agreement
between the Executive and the Company in the form set forth on
Exhibit A.

 

5. Termination
and Obligations of the Company upon Termination. This
Agreement and the Executive’s employment by the Company shall
or may be terminated, as the case may be, as set forth
below.

 

(a) Termination upon Expiration of the
Term. This Agreement and the Executive’s employment by
the Company shall terminate upon the expiration of the Term in the
event either party gives the other party timely written notice of
non-renewal in accordance with Section 3 of this
Agreement.

 

(b) Termination by the Executive.
The Executive may terminate this Agreement and his employment with
the Company as follows:

 

(i) Voluntary Resignation. For any
reason other than Good Reason (as defined below), thirty (30) days
after written notice of the Executive’s resignation is
received by the Company (“Voluntary
Resignation”).

 

(ii) For
Good Reason. For purposes of this Agreement, the
Executive’s termination of his employment will be deemed to
have been for “Good
Reason” if the Executive resigns within six (6) months
after any of the following conditions having arisen without his
prior written consent and after having given the Company written
notice of the existence of such condition within ninety (90) days
of the Executive’s knowledge of the existence of the
condition and providing the Company with thirty (30) days to remedy
the condition:

 

(A)

a material
diminution in the Executive’s Base Salary;

 

(B)

a material
diminution in the Executive’s authority, duties, or
responsibility by the assignment to him of authority, duties, or
responsibilities materially inconsistent with his position as Chief
Medical Officer;

 

 

 

 

(C)

any breach by the
Company of any material provision of this Agreement or any other
written agreement with the Executive.

 

(c) Termination by the Company. The
Company may terminate this Agreement and the Executive’s
employment by the Company immediately upon written notice to the
Executive (or his personal representative):

 

(i) Without Cause. At any time and
for any reason other than reasons set forth in Sections 5(c)(ii)
(Death), (iii) (Disability) or (iv) (Cause) (“Without Cause”);

 

(ii) Death.
Upon the death of the Executive, in which case this Agreement shall
terminate immediately; provided that, such termination shall not
prejudice any benefits payable to the Executive’s spouse or
beneficiaries which are fully vested as of the date of death
(“Death”);

 

(iii) Disability.
If the Executive is permanently disabled (as defined herein), in
which case this Agreement shall terminate immediately; provided
that, such termination shall not prejudice any benefits payable to
the Executive, the Executive’s spouse or beneficiaries which
are fully vested as of the date of the termination of this
Agreement. For purposes of this Agreement, the Executive shall be
considered “permanently
disabled” when a qualified medical doctor mutually
acceptable to the Company and the Executive or the
Executive’s personal representative shall have certified in
writing that the Executive has been unable, because of a medically
determinable physical or mental disability, to perform
substantially all of the Executive’s duties, with or without
a reasonable accommodation, for more than one hundred eighty (180)
calendar days measured from the last full day of work
(“Disability”);

 

(iv) For
Cause. The term “Cause”, as used herein, shall
mean:

 

(A) 

Any willful
material breach of the terms of this Agreement, or of any other
written agreement with the Executive, by the Executive, which
breach is not cured by the Executive within thirty (30) days after
the Company provides the Executive with written notice specifying
the nature of such breach;

 

(B) 

The
Executive’s material misappropriation of the Company’s
tangible or intangible property, or material and intentional breach
of the Confidentiality Agreement (as defined below) (provided,
however, that for this purpose, the Executive will not be deemed to
have breached the Confidentiality Agreement in connection with any
disclosure made pursuant to a court order, subpoena or other legal
obligation);

 

 

 

 

(C) 

The
Executive’s material failure to comply with the Company
Policies or any other reasonable policies and/or directives of the
Board, which failure is not cured by the Executive within thirty
(30) days after the Company provides the Executive with written
notice specifying the nature of such failure;

 

(D) 

The
Executive’s abuse of illegal drugs or any illegal substance,
or the Executive’s abuse of alcohol in any manner that
materially interferes with the performance of the Executive’s
duties under this Agreement;

 

(E) 

Any dishonest or
illegal action (including, without limitation, embezzlement) by the
Executive which is detrimental to the interest and well-being of
the Company, including, without limitation, harm to its reputation;
or

 

(F) 

The
Executive’s failure to disclose any conflict of interest
known to the Executive that the Executive may have with the Company
in a transaction between the Company and any third party which
failure is detrimental to the interest and well-being of the
Company.

 

(d) Obligations upon
Termination.

 

(i) Upon the
termination of this Agreement and the Executive’s employment
with the Company pursuant to the expiration of the Term following
the Executive’s notice of non-renewal pursuant to Section 3,
by the Executive pursuant to Section 5(b)(i) (Voluntary
Resignation), or by the Company pursuant to Section 5(c)(ii)
(Death), (iii) (Disability) or (iv) (Cause), the Company shall have
no further obligations hereunder other than the payment of all
compensation and other benefits payable to the Executive (or his
estate or heirs) through the date of such termination in accordance
with the Company’s normal payroll cycle and terms of the
applicable benefit plans and programs in existence at the time the
Executive’s employment is terminated.

 

(ii) Upon
termination of this Agreement and the Executive’s employment
with the Company by the Company pursuant to Section 5(c)(i)
(Without Cause), upon expiration of the Term following the
Company’s notice of non-renewal pursuant to Section 3, or by
the Executive pursuant to Section 5(b)(ii) (Good Reason), the
Executive shall be entitled to the following, with those benefits
described in Sections 5(d)(ii)(B), (C) and (D) specifically
conditioned upon Executive’s execution and nonrevocation of a
valid release under Section 6 and compliance with his obligations
under Section 7:

 

(A)

payment of all
compensation and other benefits payable to the Executive through
the date of such termination in accordance with the Company’s
normal payroll cycle and terms of the applicable benefit plans and
programs in existence at the time the Executive’s employment
is terminated;

 

 

 

 

(B)

payment of an
amount equal to twelve (12) months of his then current Base
Salary (less applicable withholdings), payable in a lump sum on the
sixtieth (60th) day following the
date of the Executive’s separation from service (the
“Severance Payment
Date”);

 

(C)

a lump sum payment
in an amount equal to the Target Bonus for the fiscal year in which
such termination occurred, multiplied by a fraction, the numerator
of which is the number of days during which the Executive was
employed by the Company in the fiscal year of his termination and
the denominator of which is 365 (less applicable withholdings),
with such payment to be made on the Severance Payment
Date;

 

(D)

all outstanding
equity-based compensation awards shall become fully vested and the
restrictions thereon shall lapse; provided that, any delays in the
settlement or payment of such awards that are set forth in the
applicable award agreement and that are required under Section 409A
("Section 409A") of the
Internal Revenue Code of 1986, as amended (the "Code") shall remain in effect;
and

 

(E)

reimbursement for
premium payments the Executive makes under the Consolidated Budget
Reconciliation Act (“COBRA”) to continue the Executive
and, if applicable, the Executive’s family’s health
insurance coverage under the Company’s group health insurance
plan for twelve (12) months from the date of termination.
Reimbursements for COBRA premium payments shall begin on the
Severance Payment Date and shall be made as soon as possible
following the Executive’s submission to the Company of proof
of timely payments, but not later than thirty (30) days after the
Executive’s submission of proof of timely payments; provided,
however, all such claims for reimbursement shall be submitted by
the Executive and paid by the Company no later than fifteen (15)
months following the termination of the Executive’s
employment. Any obligation for the Company to make payments for
COBRA reimbursement under this Agreement shall immediately cease
when the Executive becomes eligible for health insurance from a
subsequent employer, and the Executive shall promptly notify the
Company of such subsequent eligibility. If the Executive desires
COBRA coverage, the Executive shall bear full responsibility for
applying for COBRA coverage and nothing herein shall constitute a
guarantee of COBRA benefits. Under no circumstances will the
Executive be entitled to a cash payment or other benefit in lieu of
reimbursements for the actual costs of premiums for COBRA
continuation hereunder. The amount of expenses eligible for
reimbursement during any calendar year shall not be affected by the
amount of expenses eligible for reimbursement in any other calendar
year.

 

 

 

 

 

6. Release of Claims.
Notwithstanding any provision of this Agreement to the contrary
(other than the last sentence of this Section 6), the
Company’s obligation to provide the payments and benefits
under Section 5(d)(ii)(B), (C) and (D) of this Agreement is
conditioned upon the Executive’s timely execution and
non-revocation of an enforceable release of claims and his
compliance with his obligations under Section 7 of this Agreement.
If the Executive chooses not to execute such a release, timely
revokes his execution of the release, or fails to comply with his
obligations under Section 7 of this Agreement, then the
Company’s obligation to compensate him ceases upon the
termination of his employment except as to amounts due at the time
pursuant to Section 5(d)(ii)(A). The Company shall provide the
release of claims to the Executive within seven (7) days of his
separation from service, and the Executive must execute it within
the time period specified in the release (which shall not be longer
than forty five (45) days from the date of receipt). Such release
shall not be effective until any applicable revocation period has
expired.

 

7. Confidential Information and
Competitive Business Activities. The Executive acknowledges
that by virtue of his employment and position with the Company, he
has or will have access to confidential information of the Company,
including valuable information about its business operations and
entities with which it does business in various locations, and has
developed or will develop relationships with parties with whom it
does business in various locations. The Executive also acknowledges
that the confidential information and competitive business
activities provisions set forth in the Employee Non-Disclosure,
Invention Assignment, and Competitive Business Activities Agreement
effective as of the Effective Date hereof (the “Confidentiality Agreement”), are
reasonably necessary to protect the Company’s legitimate
business interests, are reasonable as to the time, territory and
scope of activities which are restricted, do not interfere with
public policy or public interest and are described with sufficient
accuracy and definiteness to enable him to understand the scope of
the restrictions imposed on him. The Executive acknowledges that
his failure to abide by the provisions set forth in Section 3 of
the Confidentiality Agreement would cause irreparable harm to the
Company for which legal remedies would be inadequate. Therefore, in
addition to any legal or other relief to which the Company may be
entitled by virtue of the Executive’s failure to abide by the
provisions set forth in Section 3 of the Confidentiality Agreement:
(i) the Company will be released of its obligations under this
Agreement to make any post-termination payments; (ii) the Company
may seek legal and equitable relief, including but not limited to
preliminary and permanent injunctive relief, for the
Executive’s actual or threatened failure to abide by these
provisions; (iii) the Executive will return all post-termination
payments received pursuant to this Agreement; and (iv) the
Executive will indemnify the Company for all reasonable and
documented expenses, including attorneys’ fees, incurred by
it in successfully enforcing these provisions. In the event that
the Company exercises its right to discontinue payments under this
provision and/or the Executive returns all post-termination
payments received pursuant to this Agreement, the Executive shall
remain obligated to abide by the provisions set forth in Section 3
in the Confidentiality Agreement.

 

 

 

8. Representations and
Warranties.

 

(a) The Executive
represents and warrants to the Company that the Executive’s
performance of this Agreement and as an employee of the Company
does not and will not breach any noncompetition agreement or any
agreement to keep in confidence proprietary information acquired by
the Executive in confidence or in trust prior to the
Executive’s employment by the Company. The Executive
represents and warrants to the Company that the Executive has not
entered into, and agrees not to enter into, any agreement that
conflicts with or violates this Agreement.

 

(b) The Executive
represents and warrants to the Company that the Executive has not
brought and shall not bring with the Executive to the Company, or
use in the performance of the Executive’s responsibilities
for the Company, any materials or documents of a former employer
which are not generally available to the public or which did not
belong to the Executive prior to the Executive’s employment
with the Company, unless the Executive has obtained written
authorization from the former employer or other owner for their
possession and use and provided the Company with a copy
thereof.

 

9. Notices. All notices, requests,
consents, approvals, and other communications to, upon, and between
the parties shall be in writing and shall be deemed to have been
given, delivered, made, and received when: (a) personally
delivered; (b) deposited for next day delivery by Federal Express,
or other similar overnight courier services; (c) transmitted via
telefacsimile or other similar device to the attention of the
Company’s Chief Financial Officer with receipt acknowledged;
or (d) three (3) days after being sent or mailed by certified mail,
postage prepaid and return receipt requested, addressed as
follows:

 

	

If to
the Company:

	
 

	

Tenax
Therapeutics, Inc.

	

Attn:
Chief Financial Officer

One
Copley Parkway

	

Suite
490

	

Morrisville,
NC 27560

	
 

	

If to
the Executive:

	
 

	

Stuart
Rich

	

3621
Grove Street

Skokie,
IL 60076

	
 

 

 

 

 

10. Choice of Law/Choice of
Venue/Effect/Assignment. This Agreement shall be interpreted
and governed under the laws of the State of North Carolina, without
regard to its choice of law rules, and shall be binding on and
inure to the respective benefit of the Company and its successors
and assigns and the Executive and his personal representatives. The
exclusive jurisdiction for any dispute arising under or relating to
this Agreement shall be the state or federal courts sitting in Wake
County, North Carolina, and each party hereby irrevocably consents
to the personal jurisdiction of such courts. The Company shall
require any successor (whether direct or indirect, by purchase,
merger, consolidation, reorganization or otherwise) to all or
substantially all of the business or assets of the Company, within
fifteen (15) days of such succession, expressly to assume and agree
to perform this Agreement in the same manner and to the same extent
as the Company would be required to perform if no such succession
had taken place. The Executive may not assign this Agreement or
delegate his obligations hereunder. As used in this Agreement,
“Company” shall
mean the Company and any such successor which assumes and agrees to
perform the duties and obligations of the Company under this
Agreement by operation of law or otherwise.

 

11. Entire Agreement. Except as
expressly provided in this Agreement and except for the
Confidentiality Agreement, this Agreement: (i) supersedes all other
understandings and agreements, oral or written, between the parties
with respect to the subject matter of this Agreement; and (ii)
constitutes the sole agreement between the parties with respect to
this subject matter; provided that the Transaction Agreement is
expressly preserved. Each party acknowledges that: (A) no
representations, inducements, promises or agreements, oral or
written, have been made by any party or by anyone acting on behalf
of any party, which are not embodied in this Agreement; and (B) no
agreement, statement or promise not contained in this Agreement
shall be valid. No change or modification of this Agreement shall
be valid or binding upon the parties unless such change or
modification is in writing and is signed by the
parties.

 

12. Severability. If a court of
competent jurisdiction holds that any provision or sub-part thereof
contained in this Agreement is invalid, illegal or unenforceable,
that invalidity, illegality or unenforceability shall not affect
any other provision in this Agreement.

 

13. Amendment and Waiver. No
provision of this Agreement, including the provisions of this
Section, may be amended, modified, deleted, or waived in any manner
except by a written agreement executed by the parties. Further, the
Company’s or the Executive’s waiver of any breach of a
provision of this Agreement shall not waive any subsequent breach
by the other party.

 

14. Counterparts. This Agreement
may be executed in more than one counterpart, each of which shall
be deemed an original, and all of which shall be deemed a single
agreement.

 

15. Headings. The headings herein
are for convenience only and shall not affect the interpretation of
this Agreement.

 

 

 

 

 

16. Taxes.

 

(a) Section 409A of the Internal Revenue
Code.

 

(i) Parties’
Intent. The
parties intend that the provisions of this Agreement comply with
Section 409A of the Internal Revenue Code of 1986, as amended (the
“Code”), and the
regulations thereunder (collectively, “Section 409A”), or an exemption,
and all provisions of this Agreement shall be construed in a manner
consistent with the requirements for avoiding taxes or penalties
under Section 409A. If any provision of this Agreement (or of any
award of compensation, including equity compensation or benefits)
would cause the Executive to incur any additional tax or interest
under Section 409A, the Company shall, upon the specific
request of the Executive, use its reasonable business efforts to in
good faith reform such provision to comply with Code
Section 409A; provided, that to the maximum
extent practicable, the original intent and economic benefit to the
Executive and the Company of the applicable provision shall be
maintained. The Company shall timely use its reasonable business
efforts to amend any plan or program in which the Executive
participates to bring it in compliance with Section
409A.

 

(ii) Separation
from Service. A termination of employment shall not be
deemed to have occurred for purposes of any provision of this
Agreement relating to the payment of any amounts or benefits upon
or following a termination of employment unless such termination
also constitutes a “Separation from Service” within the
meaning of Section 409A and, for purposes of any such provision of
this Agreement, references to a “termination,”
“termination of employment,” “separation from
service” or like terms shall mean Separation from
Service.

 

(iii) Separate
Payments. Each installment payment required under this
Agreement shall be considered a separate payment for purposes of
Section 409A.

 

(iv) Delayed
Distribution to Specified Employees. If the Company
determines in accordance with Sections 409A and 416(i) of the Code
and the regulations promulgated thereunder, in the Company’s
sole discretion, that the Executive is a specified employee of the
Company, determined in accordance with Section 409A, any payments
and/or benefits provided under this Agreement that constitute
“nonqualified deferred compensation” subject to Section
409A that are provided to Executive on account of his Separation
from Service shall not be provided until the day after the
six-month anniversary of Executive’s termination date
(“Specified
Employee Payment Date”). The aggregate amount of any
payments that would otherwise have been made to Executive during
such six-month period shall be paid in a lump sum to Executive on
the Specified Employee Payment Date without interest and,
thereafter, any remaining reimbursements shall be paid without delay in
accordance with their original schedule.

 

(b) Withholdings. The Company shall
withhold any amounts required from any payment due the Executive
hereunder in accordance with state and federal tax law
requirements.

 

[Signatures on following page]

 

 

 

 

IN WITNESS WHEREOF, the parties have
executed this Employment Agreement as of the day and year first
above written.

 

	
 

	

Tenax Therapeutics, Inc.

	
 

	

 

 

 

By:___/s/
Anthony DiTonno___________

Name:
Anthony DiTonno

Title:
Chief Executive Officer

 

 

 

	
 

	

Stuart Rich, MD

	
 

	

 

 

___/s/
Stuart Rich_____________________

 

 

 

 

 

[Signature Page to Executive Employment Agreement]

 

 

 

Exhibit A

 

Nonstatutory Stock Option Agreement

 

 

 

 

 

 

 

	

 

 

TENAX THERAPEUTICS INC.

2016 STOCK INCENTIVE PLAN

 

AWARD AGREEMENT

 

THIS
AWARD AGREEMENT (this “Agreement”) is made by and
between Tenax Therapeutics, Inc., a Delaware corporation (the
“Company”), and Stuart Rich, M.D. (the
“Optionee”)  in accordance
with the employment inducement grant exception to the shareholder
approval requirements of the Nasdaq Stock Market LLC (
“Nasdaq”) set forth in Nasdaq Listing Rule
5635(c)(4). Capitalized terms not defined in this Agreement
shall have the meanings given to them in the Tenax Therapeutics,
Inc. 2016 Stock Incentive Plan (the
“Plan”).

 

WITNESSETH:

 

WHEREAS, the
Optionee is providing, or has agreed to provide, services to the
Company, or Affiliate or a Subsidiary of the Company, as an
Employee or Third Party Service Provider;

 

WHEREAS, the
Company considers it desirable and in its best interests that the
Optionee be given a personal stake in the Company’s growth,
development and financial success through the grant of an option to
purchase shares of the $0.0001 par value common stock of the
Company (the “Shares”); and

 

WHEREAS, the
Compensation Committee of the Company’s Board of Directors
desires to award a stock option to Optionee as an employment
inducement grant (within the meaning of Nasdaq Listing Rule
5635(c)(4)).

 

NOW,
THEREFORE, in consideration of the premises and the mutual
agreements set forth herein, the parties agree as
follows:

 

1. Grant of Option. Effective as
of January 15, 2021 (the “Date of Grant”), the
Company hereby grants to the Optionee, an option (the
“Option”) to purchase Two Hundred Fifty Thousand
(250,000) Shares at the
Option Price per Share of $1.78 (the “Option Price”),
subject to the terms and conditions of this Agreement and
in
accordance with the employment inducement grant exception to the
shareholder approval requirements set forth in NASDAQ Listing Rule
5635(c)(4).  It is understood
that the grant of such Option is not made pursuant to the Plan or
any other equity-based incentive plan of the Company; provided,
however, that, unless inconsistent with the express terms of this
Agreement, this Agreement shall be interpreted, and the Option
shall be administered, consistent with the provisions of the Plan,
the terms of which are herein incorporated by
reference.  The future value of such Shares is
unknown and cannot be predicted with certainty. If such Shares do
not increase in value, the Option will have no value.

 

2. Term of Option. Subject to
earlier termination under Section 4 hereof, the term of the
Option shall be ten (10) years (the
“Term”).

 

3. Vesting Schedule. The Option
shall vest and become exercisable as to:

 

 

 

 

 

(a)

Sixty-Two Thousand
Five Hundred (62,500) Shares from and after the start of a Phase 3
clinical trial (the “Trial”);

 

(b)

Sixty-Two Thousand
Five Hundred (62,500) Shares from and after the database lock with
respect to the Trial;

 

(c)

Sixty-Two Thousand
Five Hundred (62,500) Shares from and after the opening of an
Investigational New Drug Application with the U.S. Food and Drug
Administration (the “FDA”);

 

(d)

Sixty-Two Thousand
Five Hundred (62,500) Shares from and after the approval from the
FDA.

 

In no
event will any portion of the Option that is not vested and
exercisable at the time of the termination of the Optionee’s
service relationship become vested and exercisable following such
termination. Further, notwithstanding any provision of the Plan or
this Agreement to the contrary, in no event will any portion of the
Option that is not vested and exercisable immediately prior to the
time of a Sale of the Company become vested and exercisable because
of such event.

 

4. Termination of Option. Except
as otherwise provided herein, the Option shall terminate on the
earliest to occur of the following:

 

(e)

The expiration of
the Term of the Option.

 

(f)

The 91st day after
termination of the Optionee’s service relationship for any
reason other than one specified in (c) or
(d) below.

 

(g)

The 366th day after
termination of the Optionee’s service relationship as a
result of the Optionee’s death, or a disability, retirement
or redundancy that is approved by the Committee for this
purpose.

 

(h)

Termination of the
Optionee’s employment relationship by the Company for Cause,
or of the Optionee’s service relationship by the Company for
reasons that would constitute Cause if the Optionee were an
employee.

 

5. Exercise of Option. The vested portion of the Option
may be exercised in whole or in part by delivery of an exercise
notice in the form attached as Exhibit A (the
“Exercise Notice”) which shall state the election to
exercise the Option and set forth the number of Shares with respect
to which the Option is being exercised. The Exercise Notice shall
be accompanied by payment of an amount equal to the aggregate
Option Price as to all exercised Shares. Payment of such amount
shall be by any of the following methods, or combination thereof,
at the election of the Optionee: (a) in cash or its
equivalent; (b) by tendering (either by actual delivery or
attestation) previously acquired Shares having an aggregate Fair
Market Value at the time of exercise equal to the Option Price;
(c) by a cashless (broker-assisted) exercise; or (d) any
other method approved or accepted by the Committee in its sole
discretion. The Option
shall be deemed to be exercised upon receipt by the Company of such
fully executed Exercise Notice accompanied by the aggregate Option
Price.

 

 

 

 

In
connection with such exercise, the Company shall have the right to
require that the Optionee make such provision, or furnish the
Company such authorization, as may be necessary or desirable so
that the Company may satisfy any obligation it has under applicable
income tax laws to withhold for income or other taxes due upon or
incident to such exercise. The Committee may, in its discretion,
permit such withholding obligation to be satisfied through the
withholding of Shares that would otherwise be delivered upon
exercise of the Option.

 

6. Non-Transferability of Option.
This Option may not be transferred in any manner otherwise than by
will or the laws of descent and distribution and, during the
Optionee’s lifetime, may only be exercised by the
Optionee.

 

7. Restrictions on Shares. This
Agreement shall be subject to all applicable laws, rules, and
regulations, and to such approvals by any governmental agencies or
stock exchange as may be required. The Optionee agrees to take all
steps the Committee determines are necessary to comply with all
applicable provisions of federal and state securities law in
exercising his or her rights under this Agreement. The Committee
may impose such restrictions on any Shares acquired pursuant to the
exercise of this Option as it deems advisable, including, without
limitation, minimum holding period requirements, restrictions under
applicable federal securities laws, under the requirements of any
stock exchange or market upon which such Shares are then listed
and/or traded, or under any blue sky or state securities laws
as may be applicable to such Shares.

 

8. Forfeiture. Where an Optionee engages in certain competitive
activity or is terminated by the Company for Cause, his or her
Option and Shares are subject to forfeiture conditions under
Section 11.3 of the Plan. Upon the occurrence of any of the
events set forth in Section 11.3 of the Plan, in addition to the
remedies provided in Section 11.3, the Company shall be entitled to
issue a stop transfer order and other documents implementing the
forfeiture to its transfer agent, the depository or any of its
nominees, and any other person with respect to this Option and the
Shares.

 

9. Successors and Assigns. The
Company may assign any of its rights under this Agreement to single
or multiple assignees, and this Agreement shall inure to the
benefit of the successors and assigns of the Company. Subject to
the restrictions on transfer herein set forth, the terms and
conditions of the Plan and this Agreement shall be binding upon the
Optionee and his or her heirs, executors, administrators,
successors and assigns.

 

10. Interpretation. Any dispute
regarding the interpretation of this Agreement shall be submitted
by the Optionee or by the Company forthwith to the Committee, which
shall review such dispute at its next regular meeting. The
resolution of such a dispute by the Committee shall be final and
binding on all parties.

 

11. Tax Consequences. The exercise
of this Option and the subsequent disposition of the Shares may
cause the Optionee to be subject to federal, state and/or foreign
taxation. The Optionee should consult a tax advisor before
exercising this Option or disposing of the Shares purchased
hereunder.

 

 

 

 

12. Acknowledgement. The Optionee
acknowledges and agrees: (i) that the Plan is discretionary in
nature and may be suspended or terminated by the Company at any
time; (ii) that the grant of the Option does not create any
contractual or other right to receive future grants of options or
any right to continue an employment or other relationship with the
Company (for the vesting period or otherwise); (iii) that the
Optionee remains subject to discharge from such relationship to the
same extent as if the Option had not been granted; (iv) that
all determinations with respect to any such future grants,
including, but not limited to, when and on what terms they shall be
made, will be at the sole discretion of the Committee;
(v) that participation in the Plan is voluntary;
(vi) that the value of the Option is an extraordinary item of
compensation that is outside the scope of the Optionee’s
employment contract if any; and (vii) that the Option is not
part of normal or expected compensation for purposes of calculating
any severance, resignation, redundancy, end of service payments,
bonuses, long-service awards, pension or retirement benefits or
similar benefits.

 

13. Employee Data Privacy. As a
condition of the grant of this Option, the Optionee consents to the
collection, use and transfer of personal data as described in this
paragraph. The Optionee understands that the Company and its
Affiliates hold certain personal information about the Optionee,
including but not limited to the Optionee’s name, home
address and telephone number, date of birth, social security
number, salary, nationality, job title, shares of common stock or
directorships held in the Company, details of all Options or other
entitlement to shares of common stock awarded, cancelled,
exercised, vested, unvested or outstanding in the Optionee’s
favor for the purpose of managing and administering the Plan
(“Data”). The Optionee further understands that the
Company and/or its Affiliates will transfer Data amongst themselves
as necessary for the purposes of implementation, administration and
management of the Optionee’s participation in the Plan, and
that the Company and/or any of its Affiliates may each further
transfer Data to any third parties assisting the Company in the
implementation, administration and management of the Plans. The
Optionee understands that these recipients may be located in the
Optionee’s country of residence or elsewhere. The Optionee
authorizes them to receive, possess, use, retain and transfer Data
in electronic or other form, for the purposes of implementing,
administering and managing the Optionee’s participation in
the Plan, including any requisite transfer of such Data as may be
required for the administration of the Plan and/or the subsequent
holding shares of common stock on the Optionee’s behalf to a
broker or other third party with whom the shares acquired on
exercise may be deposited. The Optionee understands that the
Optionee may, at any time, view the Data, require any necessary
amendments to it or withdraw the consent herein in writing by
contacting the local human resources representative.

 

14. Confidentiality. The Optionee
agrees not to disclose the terms of this offer to anyone other than
the members of the Optionee’s immediately family or the
Optionee’s counsel or financial advisors and agrees to advise
such persons of the confidential nature of this offer.

 

 

 

 

 

15. Entire Agreement; Governing
Law. The Plan is incorporated herein by reference. The Plan
and this Agreement constitute the entire agreement of the parties
with respect to the subject matter hereof and supersede in their
entirety all prior undertakings and agreements of the Company and
the Optionee with respect to the subject matter hereof, and may not
be modified adversely to the Optionee’s interest except by
means of a writing signed by the Company and Optionee. This
Agreement is governed by the internal substantive laws but not the
choice of law rules of Delaware.

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	

OPTIONEE

 

	
 

	
 

	
 

	

TENAX THERAPEUTICS, INC.

 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	

By:

	
 

	

                                                         

	

Signature

	
 

	
 

	
 

	

Name:

	
 

	

                                                         

	
 

	
 

	
 

	
 

	

Title:

	
 

	

                                                         

 

 

 

 

 

 

 

 

 

 

 

Exhibit A

 

FORM OF

EXERCISE NOTICE FOR 2016 STOCK INCENTIVE PLAN

 

 

Tenax
Therapeutics, Inc.

One
Copley Parkway, Suite 490

Morrisville,
North Carolina 27560

Attention: Stock
Plan Administrator

1. Exercise of Option. Effective
as of today,                     ,
20    , the
undersigned (the “Optionee”) hereby elects to exercise
the Optionee’s option (the “Option”) to
purchase              shares
of the Common Stock (the “Shares”) of Tenax
Therapeutics, Inc. (the “Company”) under and pursuant
to the Tenax Therapeutics, Inc. 2016 Stock Incentive Plan (the
“Plan”) and the Award Agreement with a grant date
of [                ],
2020 (the “Award”). The Grant Number of the Option
is [            ],
and the per share exercise price is $[        ].

 

2. Delivery of Payment. The
Optionee herewith delivers to the Company the aggregate exercise
price of the Option, as set forth in the Award, by means
of (check
one):

 

	
 

	

☐

	

a check
in U.S. dollars made payable to Tenax Therapeutics, Inc. or bank
transfer;

or

 

	
 

	

☐

	

(i) a
share certificate (or certificates) representing previously
acquired shares and (ii) a check in U.S. Dollars made payable to
Tenax Therapeutics, Inc. or bank transfer that, in combination,
have an aggregate value (the Fair Market Value of the shares
delivered plus the check or bank transfer amount) equal to the
aggregate exercise price of the Option.

 

3. Representations of Optionee.
The Optionee acknowledges that the Optionee has received, read and
understood the Plan and the Award and agrees to abide by and be
bound by their terms and conditions. In making the decision to
exercise the option(s) the Optionee has relied upon his or her own
independent investigations or those made by his or her
representatives, if any (including professional, financial, tax,
legal and other advisors). The Optionee (and his or her
representatives, if any) has had an opportunity to review
information with respect to the Company, desires no further
additional information concerning the Company or its operations,
and deems such information reviewed adequate to evaluate the merits
and risks of the Optionee’s investment in the
Company.

 

 

The
Optionee acknowledges that the Company is relying upon each of the
above representations in connection with the exercise of the option
and the issuance of the underlying Shares.

 

4. Rights as Shareholder. Until
the issuance of the Shares (as evidenced by the appropriate entry
on the books of the Company or of a duly authorized transfer agent
of the Company), no right to vote or receive dividends or any other
rights as a shareholder shall exist with respect to the Shares,
notwithstanding the exercise of the Option. The Shares shall be
issued to the Optionee as soon as practicable after the Option is
exercised. No adjustment shall be made for a dividend or other
right for which the record date is prior to the date of issuance
except as provided in the Plan.

 

 

 

 

 

5. Tax Consultation and
Withholding. The Optionee understands that the Optionee may
suffer adverse tax consequences as a result of the Optionee’s
purchase or disposition of the Shares. The Optionee represents that
the Optionee has consulted with any tax consultants the Optionee
deems advisable in connection with the purchase or disposition of
the Shares and that the Optionee is not relying on the Company for
any tax advice. The Optionee further understands that the
Optionee’s purchase of the Shares may give rise to an
obligation on the part of the Company to withhold for income or
other taxes due and agrees to make a payment to the Company in the
amount necessary to allow the Company to satisfy any withholding
obligations.

 

6. Restrictive Legends. The
Optionee understands and agrees that the Company shall cause the
legends set forth below or legends substantially equivalent
thereto, to be placed upon any certificate(s) evidencing ownership
of the Shares together with any other legends that may be required
by the Company or by state or federal securities laws:

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TENAX
THERAPEUTICS, INC. 2016 STOCK INCENTIVE PLAN, AS SUCH PLAN MAY BE
ALTERED, AMENDED, RESTATED OR MODIFIED FROM TIME TO TIME, AND ANY
TRANSFEREE OF THESE SECURITIES SHALL BE SUBJECT TO THE TERMS OF
SUCH PLAN. COPIES OF THE FOREGOING PLAN ARE MAINTAINED WITH THE
CORPORATE RECORDS OF THE ISSUER AND ARE AVAILABLE FOR INSPECTION AT
THE PRINCIPAL OFFICES OF THE ISSUER.

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE ALSO SUBJECT TO AN
AWARD AGREEMENT BETWEEN THE ISSUER AND THE HOLDER, AS SUCH
AGREEMENT MAY BE AMENDED, RESTATED OR MODIFIED FROM TIME TO TIME,
AND ANY TRANSFEREE OF THESE SECURITIES SHALL BE SUBJECT TO THE
TERMS OF SUCH AGREEMENT. COPIES OF THE FOREGOING AGREEMENT ARE
MAINTAINED WITH THE CORPORATE RECORDS OF THE ISSUER AND ARE
AVAILABLE FOR INSPECTION AT THE PRINCIPAL OFFICES OF THE
ISSUER.

 

7. Governing Law. This Agreement
shall be governed by the internal substantive laws but not the
choice of law rules of Delaware.

 

8. Entire Agreement. The Plan and
Award are incorporated herein by reference. This Agreement, the
Plan, and the Award constitute the entire agreement of the parties
with respect to the subject matter hereof and supersede in their
entirety all prior undertakings and agreements of the Company and
the Optionee with respect to the subject matter hereof, and may not
be modified adversely to the Optionee’s interest except by
means of a writing signed by the Company and the
Optionee.

 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	

Submitted
by:

	
 

	
 

	
 

	

Accepted
by:

	
 

	
 

	
 

	

OPTIONEE

	
 

	
 

	
 

	

TENAX THERAPEUTICS, INC.

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	

By:

	
 

	

                                                         

	

Signature

	
 

	
 

	
 

	
 

	
 

	

Name: 

	
 

	

                                                         

	

Name:

	
 

	

                                                         

	
 

	
 

	
 

	

Title:

	
 

	

                                                         

	
 

	
 

	
 

	
 

	
 

	
 

	

Date:EXHIBIT 4.21

     

      

    BIONANO GENOMICS, INC.,

      Issuer

      

      AND

      

      [TRUSTEE],

      Trustee

    _______________

     

    

    INDENTURE

    

      Dated as of [•], 20__

    _______________

     

    

    Debt Securities

     

    

    
      
        

    

    
    
      Table Of Contents

    

    

    

    
      	 	PAGE 

            
	
              ARTICLE 1 DEFINITIONS

            	
              1

            
	 	
              Section 1.01

            	
              Definitions of Terms

            	
              1

              

            
	 	 	 	 
	
              ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES

            	
              5

            
	 	
              Section 2.01

            	
              Designation and Terms of Securities

            	
              5

            
	 	
              Section 2.02

            	
              Form of Securities and Trustee’s Certificate

            	
              8

            
	 	
              Section 2.03

            	
              Denominations: Provisions for Payment

            	
              8

            
	 	
              Section 2.04

            	
              Execution and Authentications

            	
              10

              

            
	 	
              Section 2.05

            	
              Registration of Transfer and Exchange

            	
              11

            
	 	
              Section 2.06

            	
              Temporary Securities

            	
              12

            
	 	
              Section 2.07

            	
              Mutilated, Destroyed, Lost or Stolen Securities

            	
              12

            
	 	
              Section 2.08

            	
              Cancellation

            	
              13

            
	 	
              Section 2.09

            	
              Benefits of Indenture

            	
              13

            
	 	
              Section 2.10

            	
              Authenticating Agent

            	
              14

            
	 	
              Section 2.11

            	
              Global Securities

            	
              14

            
	 	
              Section 2.12

            	
              CUSIP Numbers

            	
              15

            
	 	 	 	 
	
              ARTICLE 3 REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS

            	
              16

            
	 	
              Section 3.01

            	
              Redemption

            	
              16

            
	 	
              Section 3.02

            	
              Notice of Redemption

            	
              16

            
	 	
              Section 3.03

            	
              Payment Upon Redemption

            	
              17

            
	 	
              Section 3.04

            	
              Sinking Fund

            	
              18

            
	 	
              Section 3.05

            	
              Satisfaction of Sinking Fund Payments with Securities

            	
              18

            
	 	
              Section 3.06

            	
              Redemption of Securities for Sinking Fund

            	
              18

            
	 	 	 	 
	
              ARTICLE 4 COVENANTS

            	
              18

            
	 	
              Section 4.01

            	
              Payment of Principal, Premium and Interest

            	
              18

            
	 	
              Section 4.02

            	
              Maintenance of Office or Agency

            	
              19

            
	 	
              Section 4.03

            	
              Paying Agents

            	
              19

            
	 	
              Section 4.04

            	
              Appointment to Fill Vacancy in Office of Trustee

            	
              20

            

      

      

      
        i

        
          

      

      	
              ARTICLE 5 SECURITYHOLDERS’ LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE

            	
              20

            
	 	
              Section 5.01

            	
              Company to Furnish Trustee Names and Addresses of Securityholders

            	
              20

            
	 	
              Section 5.02

            	
              Preservation Of Information; Communications With Securityholders

            	
              21

            
	 	
              Section 5.03

            	
              Reports by the Company

            	
              21

            
	 	
              Section 5.04

            	
              Reports by the Trustee

            	
              22

            
	 	 	 	 
	
              ARTICLE 6 REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT

            	
              22

            
	 	
              Section 6.01

            	
              Events of Default

            	
              22

            
	 	
              Section 6.02

            	
              Collection of Indebtedness and Suits for Enforcement by Trustee

            	
              24

            
	 	
              Section 6.03

            	
              Application of Moneys Collected

            	
              25

            
	 	
              Section 6.04

            	
              Limitation on Suits

            	
              26

            
	 	
              Section 6.05

            	
              Rights and Remedies Cumulative; Delay or Omission Not Waiver

            	
              26

            
	 	
              Section 6.06

            	
              Control by Securityholders

            	
              27

            
	 	
              Section 6.07

            	
              Undertaking to Pay Costs

            	
              27

            
	 	 	 	 
	
              ARTICLE 7 CONCERNING THE TRUSTEE

            	
              28

            
	 	
              Section 7.01

            	
              Certain Duties and Responsibilities of Trustee

            	
              28

            
	 	
              Section 7.02

            	
              Certain Rights of Trustee

            	
              29

              

            
	 	
              Section 7.03

            	
              Trustee Not Responsible for Recitals or Issuance or Securities

            	
              31

            
	 	
              Section 7.04

            	
              May Hold Securities

            	
              32

            
	 	
              Section 7.05

            	
              Moneys Held in Trust

            	
              32

            
	 	
              Section 7.06

            	
              Compensation and Reimbursement

            	
              32

            
	 	
              Section 7.07

            	
              Reliance on Officer’s Certificate

            	
              33

            
	 	
              Section 7.08

            	
              Disqualification; Conflicting Interests

            	
              33

            
	 	
              Section 7.09

            	
              Corporate Trustee Required; Eligibility

            	
              33

            
	 	
              Section 7.10

            	
              Resignation and Removal; Appointment of Successor

            	
              33

            
	 	
              Section 7.11

            	
              Acceptance of Appointment By Successor

            	
              35

            
	 	
              Section 7.12

            	
              Merger, Conversion, Consolidation or Succession to Business

            	
              36

            

      

      

      
        ii

        
          

      

      	 	
              Section 7.13

            	
              Preferential Collection of Claims Against the Company

            	
              36

            
	 	
              Section 7.14

            	
              Notice of Default.

            	
              36

            
	 	 	 	 
	
              ARTICLE 8 CONCERNING THE SECURITYHOLDERS

            	
              37

            
	 	
              Section 8.01

            	
              Evidence of Action by Securityholders

            	
              37

            
	 	
              Section 8.02

            	
              Proof of Execution by Securityholders

            	
              37

            
	 	
              Section 8.03

            	
              Who May be Deemed Owners

            	
              38

            
	 	
              Section 8.04

            	
              Certain Securities Owned by Company Disregarded

            	
              38

            
	 	
              Section 8.05

            	
              Actions Binding on Future Securityholders

            	
              38

            
	 	 	 	 
	
              ARTICLE 9 SUPPLEMENTAL INDENTURES

            	
              39

            
	 	
              Section 9.01

            	
              Supplemental Indentures Without the Consent of Securityholders

            	
              39

            
	 	
              Section 9.02

            	
              Supplemental Indentures With Consent of Securityholders

            	
              40

              

            
	 	
              Section 9.03

            	
              Effect of Supplemental Indentures

            	
              40

              

            
	 	
              Section 9.04

            	
              Securities Affected by Supplemental Indentures

            	
              40

              

            
	 	
              Section 9.05

            	
              Execution of Supplemental Indentures

            	
              41

            
	 	 	 	 
	
              ARTICLE 10 SUCCESSOR ENTITY

            	
              41

            
	 	
              Section 10.01

            	
              Company May Consolidate, Etc.

            	
              41

            
	 	
              Section 10.02

            	
              Successor Entity Substituted

            	
              42

            
	 	 	 	 
	
              ARTICLE 11 SATISFACTION AND DISCHARGE

            	
              42

            
	 	
              Section 11.01

            	
              Satisfaction and Discharge of Indenture

            	
              42

            
	 	
              Section 11.02

            	
              Discharge of Obligations

            	
              43

            
	 	
              Section 11.03

            	
              Deposited Moneys to be Held in Trust

            	
              43

            
	 	
              Section 11.04

            	
              Payment of Moneys Held by Paying Agents

            	
              43

            
	 	
              Section 11.05

            	
              Repayment to Company

            	
              44

            
	 	 	 	 
	
              ARTICLE 12 IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS

            	
              44

            
	 	
              Section 12.01

            	
              No Recourse

            	
              44

            
	 	 	 	 
	
              ARTICLE 13 MISCELLANEOUS PROVISIONS

            	
              45

            
	 	
              Section 13.01

            	
              Effect on Successors and Assigns

            	
              45

            
	 	
              Section 13.02

            	
              Actions by Successor

            	
              45

            
	 	
              Section 13.03

            	
              Surrender of Company Powers

            	
              45

            

      

      

      
        iii

        
          

      

      	 	
              Section 13.04

            	
              Notices

            	
              45

            
	 	
              Section 13.05

            	
              Governing Law; Jury Trial Waiver

            	
              45

            
	 	
              Section 13.06

            	
              Treatment of Securities as Debt

            	
              46

            
	 	
              Section 13.07

            	
              Certificates and Opinions as to Conditions Precedent

            	
              46

            
	 	
              Section 13.08

            	
              Payments on Business Days

            	
              46

            
	 	
              Section 13.09

            	
              Conflict with Trust Indenture Act

            	
              47

            
	 	
              Section 13.10

            	
              Counterparts

            	
              47

            
	 	
              Section 13.11

            	
              Separability

            	
              47

            
	 	
              Section 13.12

            	
              Compliance Certificates

            	
              47

            
	 	
              Section 13.13

            	
              Patriot Act

            	
              47

            
	 	
              Section 13.14

            	
              Force Majeure

            	
              47

            
	 	
              Section 13.12

            	
              Table of Contents; Headings

            	
              48

            

    

    

    
      iv

      
        

    

    
    INDENTURE

     

    

    Indenture, dated as of [•], 20__, among Bionano Genomics, Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):

     

    

    Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide
      for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without
      coupons, to be authenticated by the certificate of the Trustee;

     

    

    Whereas, to provide the terms and conditions upon which the Securities are to be authenticated, issued and delivered, the Company has
      duly authorized the execution of this Indenture; and

     

    

    Whereas, all things necessary to make this Indenture a valid agreement of the Company, in accordance with its terms, have been done.

     

    

    Now, Therefore, in consideration of the premises and the purchase of the Securities by the holders thereof, it is mutually covenanted
      and agreed as follows for the equal and ratable benefit of the holders of Securities:

     

    

    
      ARTICLE 1

       

        

      DEFINITIONS

    

    Section 1.01      Definitions of Terms.

     

      

    The terms defined in this Section (except as in this Indenture or any indenture supplemental hereto otherwise expressly provided or unless the context otherwise requires) for all purposes of this
      Indenture and of any indenture supplemental hereto shall have the respective meanings specified in this Section and shall include the plural as well as the singular.  All other terms used in this Indenture that are defined in the Trust Indenture Act
      of 1939, as amended, or that are by reference in such Act defined in the Securities Act of 1933, as amended (except as herein or any indenture supplemental hereto otherwise expressly provided or unless the context otherwise requires), shall have the
      meanings assigned to such terms in said Trust Indenture Act and in said Securities Act as in force at the date of the execution of this instrument.

     

    

    “Authenticating Agent” means the Trustee or an authenticating agent with respect to all or any of the series of Securities appointed by the
      Trustee pursuant to Section 2.10.

     

    

    “Bankruptcy Law” means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.

      

    

    “Board of Directors” means the Board of Directors (or the functional equivalent thereof) of the Company or any duly authorized committee of
      such Board.

     

    

    
      1

      
        

    

    “Board Resolution” means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly
      adopted by the Board of Directors (or duly authorized committee thereof) and to be in full force and effect on the date of such certification.

     

    

    “Business Day” means, with respect to any series of Securities, any day other than a day on which federal or state banking institutions in
      the Borough of Manhattan, the City of New York, or in the city of the Corporate Trust Office of the Trustee, are authorized or obligated by law, executive order or regulation to close.

     

    

     “Commission” means the Securities and Exchange Commission, as from time to time constituted, created under the Exchange Act, or, if at any
      time after the execution of this instrument such Commission is not existing and performing the duties now assigned to it under the Trust Indenture Act, then the body performing such duties at such time.

     

    

    “Company” means Bionano Genomics, Inc., a corporation duly organized and
      existing under the laws of the State of Delaware, and, subject to the provisions of Article Ten, shall also include its successors and assigns.

     

    

    “Corporate Trust Office” means the office of the Trustee at which, at any particular time, its corporate trust business shall be
      principally administered, which office at the date hereof is located at 9540 Towne Centre Drive, Suite 100, San Diego, CA 92121.

     

    

    “Custodian” means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.

     

    

    “Defaulted Interest” has the meaning set forth in Section 2.03.

     

    

    “Depositary” means, with respect to Securities of any series for which the Company shall determine that such Securities will be issued as a
      Global Security, The Depository Trust Company, another clearing agency, or any successor registered as a clearing agency under the Exchange Act, or other applicable statute or regulation, which, in each case, shall be designated by the Company
      pursuant to either Section 2.01 or 2.11.

     

    

    “Event of Default” means, with respect to Securities of a particular series, any event specified in Section 6.01, continued for the period
      of time, if any, therein designated.

     

    

    “Exchange Act” means the United States Securities and Exchange Act of 1934, as amended, and the rules and regulations promulgated by the
      Commission thereunder.

     

    

    The term “given”, “mailed”, “notify” or “sent” with respect to any notice to be given to a Securityholder pursuant to this Indenture, shall mean notice (x) given to the Depositary (or its designee)
      pursuant to the standing instructions from the Depositary or its designee, including by electronic mail in accordance with accepted practices or procedures at the Depositary (in the case of a Global Security) or (y) mailed to such Securityholder by
      first class mail, postage prepaid, at its address as it appears on the Security Register (in the case of a definitive Security).  Notice so “given” shall be deemed to include any notice to be “mailed” or “delivered,” as applicable, under this
      Indenture.

     

    

    
      2

      
        

    

    “Global Security” means a Security issued to evidence all or a part of any series of Securities which is executed by the Company and
      authenticated and delivered by the Trustee to the Depositary or pursuant to the Depositary’s instruction, all in accordance with the Indenture, which shall be registered in the name of the Depositary or its nominee.

     

    

    “Governmental Obligations” means securities that are (a) direct obligations of the United States of America for the payment of which its
      full faith and credit is pledged or (b) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States of America, the payment of which is unconditionally guaranteed as a full faith and credit
      obligation by the United States of America that, in either case, are not callable or redeemable at the option of the issuer thereof at any time prior to the stated maturity of the Securities, and shall also include a depositary receipt issued by a
      bank or trust company as custodian with respect to any such Governmental Obligation or a specific payment of principal of or interest on any such Governmental Obligation held by such custodian for the account of the holder of such depositary receipt;
      provided, however, that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depositary receipt from any amount received by the custodian in respect of the Governmental
      Obligation or the specific payment of principal of or interest on the Governmental Obligation evidenced by such depositary receipt.

     

    

    “herein”, “hereof” and “hereunder”, and other words of similar import, refer to this Indenture as a whole and not to any particular Article, Section or other subdivision.

     

    

    “Indenture” means this instrument as originally executed or as it may from time to time be supplemented or amended by one or more
      indentures supplemental hereto entered into in accordance with the terms hereof and shall include the terms of particular series of Securities established as contemplated by Section 2.01.

     

    

    “Interest Payment Date”, when used with respect to any installment of interest on a Security of a particular series, means the date
      specified in such Security or in a Board Resolution or in an indenture supplemental hereto with respect to such series as the fixed date on which an installment of interest with respect to Securities of that series is due and payable.

     

    

    “Officer” means, with respect to the Company, the chairman of the Board of Directors, a chief executive officer, a president, a chief
      financial officer, a chief operating officer, any executive vice president, any senior vice president, any vice president, the treasurer or any assistant treasurer, the controller or any assistant controller or the secretary or any assistant
      secretary.

     

    

     “Officer’s Certificate” means a certificate signed by any Officer.  Each such certificate shall include the statements provided for in
      Section 13.07, if and to the extent required by the provisions thereof.

     

    

    
      3

      
        

    

    “Opinion of Counsel” means an opinion in writing subject to customary exceptions of legal counsel, who may be an employee of or counsel for
      the Company, that is delivered to the Trustee in accordance with the terms hereof.  Each such opinion shall include the statements provided for in Section 13.07, if and to the extent required by the provisions thereof.

     

    

    “Outstanding”, when used with reference to Securities of any series, means, subject to the provisions of Section 8.04, as of any particular
      time, all Securities of that series theretofore authenticated and delivered by the Trustee under this Indenture, except (a) Securities theretofore canceled by the Trustee or any paying agent, or delivered to the Trustee or any paying agent for
      cancellation or that have previously been canceled; (b) Securities or portions thereof for the payment or redemption of which moneys or Governmental Obligations in the necessary amount shall have been deposited in trust with the Trustee or with any
      paying agent (other than the Company) or shall have been set aside and segregated in trust by the Company (if the Company shall act as its own paying agent); provided, however, that if such Securities or portions of such Securities are to be redeemed
      prior to the maturity thereof, notice of such redemption shall have been given as provided in Article Three, or provision satisfactory to the Trustee shall have been made for giving such notice; and (c) Securities in lieu of or in substitution for
      which other Securities shall have been authenticated and delivered pursuant to the terms of Section 2.07.

     

    

    “Person” means any individual, corporation, partnership, joint venture, joint-stock company, limited liability company, association, trust,
      unincorporated organization, any other entity or organization, including a government or political subdivision or an agency or instrumentality thereof.

     

    

    “Predecessor Security” of any particular Security means every previous Security evidencing all or a portion of the same debt as that
      evidenced by such particular Security; and, for the purposes of this definition, any Security authenticated and delivered under Section 2.07 in lieu of a lost, destroyed or stolen Security shall be deemed to evidence the same debt as the lost,
      destroyed or stolen Security.

     

    

    “Responsible Officer” when used with respect to the Trustee means any officer within the Corporate Trust Office of the Trustee (or any
      successor group of the Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers and also means, with respect to a particular corporate trust matter, any other
      officer to whom such matter is referred because of his or her knowledge of and familiarity with the particular subject and in each case who shall have direct responsibility for the administration of this Indenture.

     

    

     “Securities” has the meaning stated in the first recital of this Indenture and more particularly means any Securities authenticated and
      delivered under this Indenture.

     

    

    “Securities Act” means the Securities Act of 1933, as amended.

     

    

    “Securityholder”, “holder of Securities”, “registered

        holder”, or other similar term, means the Person or Persons in whose name or names a particular Security is registered on the Security Register kept for that purpose in accordance with the terms of this Indenture.

     

    

    
      4

      
        

    

     “Security Register” and “Security Registrar” shall have the meanings as set
      forth in Section 2.05.

     

    

    “Subsidiary” means, with respect to any Person, any corporation, association, partnership or other business entity of which more than 50% of the total voting
      power of shares of capital stock or other interests (including partnership interests) entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, general partners or trustees thereof is at the time
      owned or controlled, directly or indirectly, by (i) such Person; (ii) such Person and one or more Subsidiaries of such Person; or (iii) one or more Subsidiaries of such Person.

    

    

    “Trustee” means _________________________, and, subject to the provisions of Article Seven, shall also include its successors and assigns,
      and, if at any time there is more than one Person acting in such capacity hereunder, “Trustee” shall mean each such Person.  The term “Trustee” as used with respect to a particular series of the Securities shall mean the trustee with respect to that
      series.

     

    

    “Trust Indenture Act” means the Trust Indenture Act of 1939, as amended.

     

    

    “U.S.A. Patriot Act” means the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct
      Terrorism Act of 2001, Pub. L. 107-56, as amended and signed into law October 26, 2001.

     

    

    ARTICLE 2

     

      

    ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND

    EXCHANGE OF SECURITIES

     

      

    Section 2.01      Designation and Terms of Securities.

     

    

    (a)       The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is unlimited.  The Securities may be issued in one or more
      series up to the aggregate principal amount of Securities of that series from time to time authorized by or pursuant to a Board Resolution or pursuant to one or more indentures supplemental hereto.  Prior to the initial issuance of Securities of any
      series, there shall be established in or pursuant to a Board Resolution, and set forth in an Officer’s Certificate, or established in one or more indentures supplemental hereto:

     

      

    (1)        the title of the Securities of the series (which shall distinguish
        the Securities of that series from all other Securities);

     

      

    (2)        any limit upon the aggregate principal amount of the Securities of
        that series that may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of that series);

     

      

    
      5

      
        

    

    (3)        the maturity date or dates on which the principal of the
        Securities of the series is payable;

     

      

    (4)        the form of the Securities of the series including the form of the
        certificate of authentication for such series;

     

      

    (5)        the applicability of any guarantees;

     

      

    (6)        whether or not the Securities will be secured or unsecured, and
        the terms of any secured debt;

     

      

    (7)        whether the Securities rank as senior debt, senior subordinated
        debt, subordinated debt or any combination thereof, and the terms of any subordination;

     

      

    (8)        if the price (expressed as a percentage of the aggregate principal
        amount thereof) at which such Securities will be issued is a price other than the principal amount thereof, the portion of the principal amount thereof payable upon declaration of acceleration of the maturity thereof, or if applicable, the portion
        of the principal amount of such Securities that is convertible into another security or the method by which any such portion shall be determined;

     

      

    (9)        the interest rate or rates, which may be fixed or variable, or the
        method for determining the rate and the date interest will begin to accrue, the dates interest will be payable and the regular record dates for interest payment dates or the method for determining such dates;

     

      

    (10)      the Company’s right, if any, to defer the payment of interest and
        the maximum length of any such deferral period;

     

      

    (11)       if applicable, the date or dates after which, or the period or
        periods during which, and the price or prices at which, the Company may at its option, redeem the series of Securities pursuant to any optional or provisional redemption provisions and the terms of those redemption provisions;

     

      

    (12)      the date or dates, if any, on which, and the price or prices at
        which the Company is obligated, pursuant to any mandatory sinking fund or analogous fund provisions or otherwise, to redeem, or at the Securityholder’s option to purchase, the series of Securities and the currency or currency unit in which the
        Securities are payable;

     

      

    (13)      the denominations in which the Securities of the series shall be
        issuable, if other than denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof;

     

      

    (14)      any and all terms, if applicable, relating to any auction or
        remarketing of the Securities of that series and any security for the obligations of the Company with respect to such Securities and any other terms which may be advisable in connection with the marketing of Securities of that series;

     

      

    
      6

      
        

    

    (15)      whether the Securities of the series shall be issued in whole or in
        part in the form of a Global Security or Securities; the terms and conditions, if any, upon which such Global Security or Securities may be exchanged in whole or in part for other individual Securities; and the Depositary for such Global Security
        or Securities;

     

      

    (16)      if applicable, the provisions relating to conversion or exchange of
        any Securities of the series and the terms and conditions upon which such Securities will be so convertible or exchangeable, including the conversion or exchange price, as applicable, or how it will be calculated and may be adjusted, any mandatory
        or optional (at the Company’s option or the holders’ option) conversion or exchange features, the applicable conversion or exchange period and the manner of settlement for any conversion or exchange, which may, without limitation, include the
        payment of cash as well as the delivery of securities;

     

      

    (17)      if other than the full principal amount thereof, the portion of the
        principal amount of Securities of the series which shall be payable upon declaration of acceleration of the maturity thereof pursuant to Section 6.01;

     

      

    (18)      additions to or changes in the covenants applicable to the series
        of Securities being issued, including, among others, the consolidation, merger or sale covenant;

     

      

    (19)      additions to or changes in the Events of Default with respect to
        the Securities and any change in the right of the Trustee or the Securityholders to declare the principal, premium, if any, and interest, if any, with respect to such Securities to be due and payable;

     

      

    (20)      additions to or changes in or deletions of the provisions relating
        to covenant defeasance and legal defeasance;

     

      

    (21)      additions to or changes in the provisions relating to satisfaction
        and discharge of this Indenture;

     

      

    (22)      additions to or changes in the provisions relating to the
        modification of this Indenture both with and without the consent of Securityholders of Securities issued under this Indenture;

     

      

    (23)      the currency of payment of Securities if other than U.S. dollars
        and the manner of determining the equivalent amount in U.S. dollars;

     

      

    (24)      whether interest will be payable in cash or additional Securities
        at the Company’s or the Securityholders’ option and the terms and conditions upon which the election may be made;

     

      

    (25)      the terms and conditions, if any, upon which the Company shall pay
        amounts in addition to the stated interest, premium, if any and principal amounts of the Securities of the series to any Securityholder that is not a “United States person” for federal tax purposes;

     

      

    
      7

      
        

    

    (26)      any restrictions on transfer, sale or assignment of the Securities
        of the series; and

     

      

    (27)       any other specific terms, preferences, rights or limitations of,
        or restrictions on, the Securities, any other additions or changes in the provisions of this Indenture, and any terms that may be required by us or advisable under applicable laws or regulations.

     

      

    All Securities of any one series shall be substantially identical except as may otherwise be provided in or pursuant to any such Board Resolution or in any indentures supplemental hereto.

      

    

    If any of the terms of the series are established by action taken pursuant to a Board Resolution of the Company, a copy of an appropriate record of such action shall be certified by the secretary or
      an assistant secretary of the Company and delivered to the Trustee at or prior to the delivery of the Officer’s Certificate of the Company setting forth the terms of the series.

     

    

    Securities of any particular series may be issued at various times, with different dates on which the principal or any installment of principal is payable, with different rates of interest, if any,
      or different methods by which rates of interest may be determined, with different dates on which such interest may be payable and with different redemption dates.

     

    

    Section 2.02      Form of Securities and Trustee’s Certificate.

     

    

    The Securities of any series and the Trustee’s certificate of authentication to be borne by such Securities shall be substantially of the tenor and purport as set forth in one or more indentures
      supplemental hereto or as provided in a Board Resolution, and set forth in an Officer’s Certificate, and they may have such letters, numbers or other marks of identification or designation and such legends or endorsements printed, lithographed or
      engraved thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this Indenture, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation
      of any securities exchange on which Securities of that series may be listed, or to conform to usage.

     

    

    Section 2.03      Denominations: Provisions for Payment.

     

      

    The Securities shall be issuable as registered Securities and in the denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof, subject to Section 2.01(a)(13).  The
      Securities of a particular series shall bear interest payable on the dates and at the rate specified with respect to that series.  Subject to Section 2.01(a)(23), the principal of and the interest on the Securities of any series, as well as any
      premium thereon in case of redemption or repurchase thereof prior to maturity, and any cash amount due upon conversion or exchange thereof, shall be payable in the coin or currency of the United States of America that at the time is legal tender for
      public and private debt, at the office or agency of the Company maintained for that purpose.  Each Security shall be dated the date of its authentication.  Interest on the Securities shall be computed on the basis of a 360-day year composed of twelve
      30-day months.

     

    

    
      8

      
        

    

    The interest installment on any Security that is payable, and is punctually paid or duly provided for, on any Interest Payment Date for Securities of that series shall be paid to the Person in whose
      name said Security (or one or more Predecessor Securities) is registered at the close of business on the regular record date for such interest installment.  In the event that any Security of a particular series or portion thereof is called for
      redemption and the redemption date is subsequent to a regular record date with respect to any Interest Payment Date and prior to such Interest Payment Date, interest on such Security will be paid upon presentation and surrender of such Security as
      provided in Section 3.03.

     

    

    Any interest on any Security that is payable, but is not punctually paid or duly provided for, on any Interest Payment Date for Securities of the same series (herein called “Defaulted Interest”)
      shall forthwith cease to be payable to the registered holder on the relevant regular record date by virtue of having been such holder; and such Defaulted Interest shall be paid by the Company, at its election, as provided in clause (1) or clause (2)
      below:

     

    

    (1)        The Company may make payment of any Defaulted Interest on
        Securities to the Persons in whose names such Securities (or their respective Predecessor Securities) are registered in the Security Register at the close of business on a special record date for the payment of such Defaulted Interest, which shall
        be fixed in the following manner: the Company shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each such Security and the date of the proposed payment, and at the same time the Company shall deposit
        with the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest or shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such
        money when deposited to be held in trust for the benefit of the Persons entitled to such Defaulted Interest as in this clause provided.  Thereupon the Trustee shall fix a special record date for the payment of such Defaulted Interest which shall
        not be more than 15 nor less than 10 days prior to the date of the proposed payment and not less than 10 days after the receipt by the Trustee of the notice of the proposed payment.  The Trustee shall promptly notify the Company of such special
        record date and, in the name and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted Interest and the special record date therefor to be sent to each Securityholder not less than 10 days prior to such special
        record date.  Notice of the proposed payment of such Defaulted Interest and the special record date therefor having been sent as aforesaid, such Defaulted Interest shall be paid to the Persons in whose names such Securities (or their respective
        Predecessor Securities) are registered in the Security Register on such special record date.

     

      

    (2)        The Company may make payment of any Defaulted Interest on any
        Securities in any other lawful manner not inconsistent with the requirements of any securities exchange on which such Securities may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Company to the
        Trustee of the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable by the Trustee.

     

      

    
      9

      
        

    

    Unless otherwise set forth in a Board Resolution or one or more indentures supplemental hereto establishing the terms of any series of Securities pursuant
      to Section 2.01 hereof, the term “regular record date” as used in this Section with respect to a series of Securities and any Interest Payment Date for such series shall mean either the fifteenth day of the month immediately preceding the month in
      which an Interest Payment Date established for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date is the first day of a month, or the first day of the month in which an Interest Payment Date established for such
      series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date is the fifteenth day of a month, whether or not such date is a Business Day.

     

    

    Subject to the foregoing provisions of this Section, each Security of a series delivered under this Indenture upon transfer of or in exchange for or in lieu of any other Security of such series shall
      carry the rights to interest accrued and unpaid, and to accrue, that were carried by such other Security.

     

    

    Section 2.04      Execution and Authentications.

     

      

    The Securities shall be signed on behalf of the Company by one of its Officers.  Signatures may be in the form of a manual or facsimile signature.

     

    

    The Company may use the facsimile signature of any Person who shall have been an Officer (at the time of execution), notwithstanding the fact that at the time the Securities shall be authenticated
      and delivered or disposed of such Person shall have ceased to be such an officer of the Company.  The Securities may contain such notations, legends or endorsements required by law, stock exchange rule or usage.  Each Security shall be dated the date
      of its authentication by the Trustee.

     

    

    A Security shall not be valid until authenticated manually by an authorized signatory of the Trustee, or by an Authenticating Agent.  Such signature shall be conclusive evidence that the Security so
      authenticated has been duly authenticated and delivered hereunder and that the holder is entitled to the benefits of this Indenture.  At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver
      Securities of any series executed by the Company to the Trustee for authentication, together with a written order of the Company for the authentication and delivery of such Securities, signed by an Officer, and the Trustee in accordance with such
      written order shall authenticate and deliver such Securities.

     

    

    Upon the Company’s delivery of any such authentication order to the Trustee at any time after the initial issuance of Securities under this Indenture, the Trustee shall be provided with, and (subject
      to Sections 315(a) through 315(d) of the Trust Indenture Act) shall be fully protected in relying upon, (1) an Opinion of Counsel or reliance letter and (2) an Officer’s Certificate stating that all conditions precedent to the execution,
      authentication and delivery of such Securities are in conformity with the provisions of this Indenture.

     

    

    The Trustee shall not be required to authenticate such Securities if the issue of such Securities pursuant to this Indenture will affect the Trustee’s own rights, duties or immunities under the
      Securities and this Indenture or otherwise in a manner that is not reasonably acceptable to the Trustee.

     

    

    
      10

      
        

    

    Section 2.05      Registration of Transfer and Exchange.

     

      

    (a)        Securities of any series may be exchanged upon presentation thereof at the office or agency of the Company designated for such purpose, for other Securities of such
      series of authorized denominations, and for a like aggregate principal amount, upon payment of a sum sufficient to cover any tax or other governmental charge in relation thereto, all as provided in this Section.  In respect of any Securities so
      surrendered for exchange, the Company shall execute, the Trustee shall authenticate and such office or agency shall deliver in exchange therefor the Security or Securities of the same series that the Securityholder making the exchange shall be
      entitled to receive, bearing numbers not contemporaneously outstanding.

     

    

    (b)       The Company shall keep, or cause to be kept, at its office or agency designated for such purpose a register or registers (herein referred to as the “Security Register”)
      in which, subject to such reasonable regulations as it may prescribe, the Company shall register the Securities and the transfers of Securities as in this Article provided and which at all reasonable times shall be open for inspection by the
      Trustee.  The registrar for the purpose of registering Securities and transfer of Securities as herein provided shall be appointed as authorized by Board Resolution or Supplemental Indenture (the “Security Registrar”).

     

    

    Upon surrender for transfer of any Security at the office or agency of the Company designated for such purpose, the Company shall execute, the Trustee shall authenticate and such office or agency
      shall deliver in the name of the transferee or transferees a new Security or Securities of the same series as the Security presented for a like aggregate principal amount.

     

    

    The Company initially appoints the Trustee as Security Registrar for each series of Securities.

     

    

    All Securities presented or surrendered for exchange or registration of transfer, as provided in this Section, shall be accompanied (if so required by the Company or the Security Registrar) by a
      written instrument or instruments of transfer, in form satisfactory to the Company or the Security Registrar, duly executed by the registered holder or by such holder’s duly authorized attorney in writing.

     

    

    (c)        Except as provided pursuant to Section 2.01 pursuant to a Board Resolution, and set forth in an Officer’s Certificate, or established in one or more indentures
      supplemental to this Indenture, no service charge shall be made for any exchange or registration of transfer of Securities, or issue of new Securities in case of partial redemption of any series or repurchase, conversion or exchange of less than the
      entire principal amount of a Security, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge in relation thereto, other than exchanges pursuant to Section 2.06, Section 3.03(b) and Section 9.04 not
      involving any transfer.

     

      

    (d)       The Company and the Security Registrar shall not be required (i) to issue, exchange or register the transfer of any Securities during a period beginning at the opening of
      business 15 days before the day of the sending of a notice of redemption of less than all the Outstanding Securities of the same series and ending at the close of business on the day of such sending, nor (ii) to register the transfer of or exchange
      any Securities of any series or portions thereof called for redemption or surrendered for repurchase, but not validly withdrawn, other than the unredeemed portion of any such Securities being redeemed in part or not surrendered for repurchase, as the
      case may be.  The provisions of this Section 2.05 are, with respect to any Global Security, subject to Section 2.11 hereof.

     

      

    
      11

      
        

    

    The Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this Indenture or under applicable law with respect to
      any transfer of any interest in any Security (including any transfers between or among Depositary participants or beneficial owners of interests in any Global Security) other than to require delivery of such certificates and other documentation or
      evidence as are expressly required by, and to do so if and when expressly required by the terms of, this Indenture, and to examine the same to determine substantial compliance as to form with the express requirements hereof.

     

    

    Section 2.06      Temporary Securities.

     

      

    Pending the preparation of definitive Securities of any series, the Company may execute, and the Trustee shall authenticate and deliver, temporary Securities (printed, lithographed or typewritten) of
      any authorized denomination.  Such temporary Securities shall be substantially in the form of the definitive Securities in lieu of which they are issued, but with such omissions, insertions and variations as may be appropriate for temporary
      Securities, all as may be determined by the Company.  Every temporary Security of any series shall be executed by the Company and be authenticated by the Trustee upon the same conditions and in substantially the same manner, and with like effect, as
      the definitive Securities of such series.  Without unnecessary delay the Company will execute and will furnish definitive Securities of such series and thereupon any or all temporary Securities of such series may be surrendered in exchange therefor
      (without charge to the Securityholders), at the office or agency of the Company designated for the purpose, and the Trustee shall authenticate and such office or agency shall deliver in exchange for such temporary Securities an equal aggregate
      principal amount of definitive Securities of such series, unless the Company advises the Trustee to the effect that definitive Securities need not be executed and furnished until further notice from the Company.  Until so exchanged, the temporary
      Securities of such series shall be entitled to the same benefits under this Indenture as definitive Securities of such series authenticated and delivered hereunder.

     

    

    Section 2.07      Mutilated, Destroyed, Lost or Stolen Securities.

     

      

    In case any temporary or definitive Security shall become mutilated or be destroyed, lost or stolen, the Company (subject to the next succeeding sentence) shall execute, and upon the Company’s
      request the Trustee (subject as aforesaid) shall authenticate and deliver, a new Security of the same series, bearing a number not contemporaneously outstanding, in exchange and substitution for the mutilated Security, or in lieu of and in
      substitution for the Security so destroyed, lost or stolen.  In every case the applicant for a substituted Security shall furnish to the Company and the Trustee such security or indemnity as may be required by them to save each of them harmless, and,
      in every case of destruction, loss or theft, the applicant shall also furnish to the Company and the Trustee evidence to their satisfaction of the destruction, loss or theft of the applicant’s Security and of the ownership thereof.  The Trustee may
      authenticate any such substituted Security and deliver the same upon the written request or authorization of any officer of the Company.  Upon the issuance of any substituted Security, the Company may require the payment of a sum sufficient to cover
      any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith.

     

    

    
      12

      
        

    

    In case any Security that has matured or is about to mature shall become mutilated or be destroyed, lost or stolen, the Company may, instead of issuing a substitute Security, pay or authorize the
      payment of the same (without surrender thereof except in the case of a mutilated Security) if the applicant for such payment shall furnish to the Company and the Trustee such security or indemnity as they may require to save them harmless, and, in
      case of destruction, loss or theft, evidence to the satisfaction of the Company and the Trustee of the destruction, loss or theft of such Security and of the ownership thereof.

     

    

    Every replacement Security issued pursuant to the provisions of this Section shall constitute an additional contractual obligation of the Company whether or not the mutilated, destroyed, lost or
      stolen Security shall be found at any time, or be enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and proportionately with any and all other Securities of the same series duly issued hereunder.  All
      Securities shall be held and owned upon the express condition that the foregoing provisions are exclusive with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities, and shall preclude (to the extent lawful) any and
      all other rights or remedies, notwithstanding any law or statute existing or hereafter enacted to the contrary with respect to the replacement or payment of negotiable instruments or other securities without their surrender.

     

    

    Section 2.08      Cancellation.

     

    

    All Securities surrendered for the purpose of payment, redemption, repurchase, exchange, registration of transfer or conversion shall, if surrendered to the Company or any paying agent (or any other
      applicable agent), be delivered to the Trustee for cancellation, or, if surrendered to the Trustee, shall be cancelled by it, and no Securities shall be issued in lieu thereof except as expressly required or permitted by any of the provisions of this
      Indenture.  On request of the Company at the time of such surrender, the Trustee shall deliver to the Company canceled Securities held by the Trustee.  In the absence of such request the Trustee may dispose of canceled Securities in accordance with
      its standard procedures and deliver a certificate of disposition to the Company.  If the Company shall otherwise acquire any of the Securities, however, such acquisition shall not operate as a redemption or satisfaction of the indebtedness
      represented by such Securities unless and until the same are delivered to the Trustee for cancellation.

     

    

    Section 2.09      Benefits of Indenture.

     

      

    Nothing in this Indenture or in the Securities, express or implied, shall give or be construed to give to any Person, other than the parties hereto and the holders of the Securities any legal or
      equitable right, remedy or claim under or in respect of this Indenture, or under any covenant, condition or provision herein contained; all such covenants, conditions and provisions being for the sole benefit of the parties hereto and of the holders
      of the Securities.

     

    

    
      13

      
        

    

    Section 2.10      Authenticating Agent.

     

    

    So long as any of the Securities of any series remain Outstanding there may be an Authenticating Agent for any or all such series of Securities which the Trustee shall have the right to appoint. 
      Said Authenticating Agent shall be authorized to act on behalf of the Trustee to authenticate Securities of such series issued upon exchange, transfer or partial redemption, repurchase or conversion thereof, and Securities so authenticated shall be
      entitled to the benefits of this Indenture and shall be valid and obligatory for all purposes as if authenticated by the Trustee hereunder.  All references in this Indenture to the authentication of Securities by the Trustee shall be deemed to
      include authentication by an Authenticating Agent for such series.  Each Authenticating Agent shall be acceptable to the Company and shall be a corporation that has a combined capital and surplus, as most recently reported or determined by it,
      sufficient under the laws of any jurisdiction under which it is organized or in which it is doing business to conduct a trust business, and that is otherwise authorized under such laws to conduct such business and is subject to supervision or
      examination by federal or state authorities.  If at any time any Authenticating Agent shall cease to be eligible in accordance with these provisions, it shall resign immediately.

     

    

    Any Authenticating Agent may at any time resign by giving written notice of resignation to the Trustee and to the Company.  The Trustee may at any time (and upon request by the Company shall)
      terminate the agency of any Authenticating Agent by giving written notice of termination to such Authenticating Agent and to the Company.  Upon resignation, termination or cessation of eligibility of any Authenticating Agent, the Trustee may appoint
      an eligible successor Authenticating Agent acceptable to the Company.  Any successor Authenticating Agent, upon acceptance of its appointment hereunder, shall become vested with all the rights, powers and duties of its predecessor hereunder as if
      originally named as an Authenticating Agent pursuant hereto.

     

    

    Section 2.11      Global Securities.

     

    

    (a)       If the Company shall establish pursuant to Section 2.01 that the Securities of a particular series are to be issued as a Global Security, then the Company shall execute
      and the Trustee shall, in accordance with Section 2.04, authenticate and deliver, a Global Security that (i) shall represent, and shall be denominated in an amount equal to the aggregate principal amount of, all of the Outstanding Securities of such
      series, (ii) shall be registered in the name of the Depositary or its nominee, (iii) shall be delivered by the Trustee to the Depositary or pursuant to the Depositary’s instruction (or if the Depositary names the Trustee as its custodian, retained by
      the Trustee), and (iv) shall bear a legend substantially to the following effect: “Except as otherwise provided in Section 2.11 of the Indenture, this Security may be transferred, in whole but not in part, only to another nominee of the Depositary or
      to a successor Depositary or to a nominee of such successor Depositary.”

     

    

    (b)       Notwithstanding the provisions of Section 2.05, the Global Security of a series may be transferred, in whole but not in part and in the manner provided in Section 2.05,
      only to another nominee of the Depositary for such series, or to a successor Depositary for such series selected or approved by the Company or to a nominee of such successor Depositary.

     

      

    
      14

      
        

    

    (c)        If at any time the Depositary for a series of the Securities notifies the Company that it is unwilling or unable to continue as Depositary for such series or if at any
      time the Depositary for such series shall no longer be registered or in good standing under the Exchange Act, or other applicable statute or regulation, and a successor Depositary for such series is not appointed by the Company within 90 days after
      the Company receives such notice or becomes aware of such condition, as the case may be, or if an Event of Default has occurred and is continuing and the Company has received a request from the Depositary or from the Trustee, this Section 2.11 shall
      no longer be applicable to the Securities of such series and the Company will execute, and subject to Section 2.04, the Trustee will authenticate and deliver the Securities of such series in definitive registered form without coupons, in authorized
      denominations, and in an aggregate principal amount equal to the principal amount of the Global Security of such series in exchange for such Global Security.  In addition, the Company may at any time determine that the Securities of any series shall
      no longer be represented by a Global Security and that the provisions of this Section 2.11 shall no longer apply to the Securities of such series.  In such event the Company will execute and, subject to Section 2.04, the Trustee, upon receipt of an
      Officer’s Certificate evidencing such determination by the Company, will authenticate and deliver the Securities of such series in definitive registered form without coupons, in authorized denominations, and in an aggregate principal amount equal to
      the principal amount of the Global Security of such series in exchange for such Global Security.  Upon the exchange of the Global Security for such Securities in definitive registered form without coupons, in authorized denominations, the Global
      Security shall be canceled by the Trustee.  Such Securities in definitive registered form issued in exchange for the Global Security pursuant to this Section 2.11(c) shall be registered in such names and in such authorized denominations as the
      Depositary, pursuant to instructions from its direct or indirect participants or otherwise, shall instruct the Trustee.  The Trustee shall deliver such Securities to the Depositary for delivery to the Persons in whose names such Securities are so
      registered.

     

      

    Section 2.12      CUSIP Numbers.

     

      

    The Company in issuing the Securities may use “CUSIP” numbers (if then generally in use), and, if so, the Trustee shall use “CUSIP” numbers in notices of redemption as a convenience to
      Securityholders; provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained in any notice of a redemption and that reliance may be placed only on
      the other elements of identification printed on the Securities, and any such redemption shall not be affected by any defect in or omission of such numbers.  The Company will promptly notify the Trustee of any change in the “CUSIP” numbers.

    

    

    
      15

      
        

    

    ARTICLE 3
       

        

      REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS

       

        

    

    Section 3.01      Redemption.

     

    

    The Company may redeem the Securities of any series issued hereunder on and after the dates and in accordance with the terms established for such series pursuant to Section 2.01 hereof.

     

    

    Section 3.02      Notice of Redemption.

     

    

    (a)       In case the Company shall desire to exercise such right to redeem all or, as the case may be, a portion of the Securities of any series in accordance with any right the
      Company reserved for itself to do so pursuant to Section 2.01 hereof, the Company shall, or shall cause the Trustee to, give notice of such redemption to holders of the Securities of such series to be redeemed by mailing (or with regard to any Global
      Security held in book entry form, by electronic mail in accordance with the applicable procedures of the Depositary), a notice of such redemption not less than 30 days and not more than 90 days before the date fixed for redemption of that series to
      such Securityholders, unless a shorter period is specified in the Securities to be redeemed.  Any notice that is mailed in the manner herein provided shall be conclusively presumed to have been duly given, whether or not the registered holder
      receives the notice.  In any case, failure duly to give such notice to the holder of any Security of any series designated for redemption in whole or in part, or any defect in the notice, shall not affect the validity of the proceedings for the
      redemption of any other Securities of such series or any other series.  In the case of any redemption of Securities prior to the expiration of any restriction on such redemption provided in the terms of such Securities or elsewhere in this Indenture,
      the Company shall furnish the Trustee with an Officer’s Certificate evidencing compliance with any such restriction.

     

      

    Each such notice of redemption shall identify the Securities to be redeemed (including CUSIP numbers, if any), specify the date fixed for redemption and the redemption price at which Securities of
      that series are to be redeemed, and shall state that payment of the redemption price of such Securities to be redeemed will be made at the office or agency of the Company, upon presentation and surrender of such Securities, that interest accrued to
      the date fixed for redemption will be paid as specified in said notice, that from and after said date interest will cease to accrue and that the redemption is from a sinking fund, if such is the case.  If less than all the Securities of a series are
      to be redeemed, the notice to the holders of Securities of that series to be redeemed in part shall specify the particular Securities to be so redeemed.

     

    

    In case any Security is to be redeemed in part only, the notice that relates to such Security shall state the portion of the principal amount thereof to be redeemed, and shall state that on and after
      the redemption date, upon surrender of such Security, a new Security or Securities of such series in principal amount equal to the unredeemed portion thereof will be issued.

     

    

    
      16

      
        

    

    (b)       If less than all the Securities of a series are to be redeemed, the Company shall give the Trustee at least 45 days’ notice (unless a shorter notice shall be satisfactory
      to the Trustee) in advance of the date fixed for redemption as to the aggregate principal amount of Securities of the series to be redeemed, and thereupon the Securities to be redeemed shall be selected, by lot, on a pro rata basis, or in such other
      manner as the Company shall deem appropriate and fair in its discretion and that may provide for the selection of a portion or portions (equal to one thousand U.S. dollars ($1,000) or any integral multiple thereof) of the principal amount of such
      Securities of a denomination larger than $1,000, the Securities to be redeemed and shall thereafter promptly notify the Company in writing of the numbers of the Securities to be redeemed, in whole or in part.  The Company may, if and whenever it
      shall so elect, by delivery of instructions signed on its behalf by an Officer, instruct the Trustee or any paying agent to call all or any part of the Securities of a particular series for redemption and to give notice of redemption in the manner
      set forth in this Section, such notice to be in the name of the Company or its own name as the Trustee or such paying agent may deem advisable.  In any case in which notice of redemption is to be given by the Trustee or any such paying agent, the
      Company shall deliver or cause to be delivered to, or permit to remain with, the Trustee or such paying agent, as the case may be, such Security Register, transfer books or other records, or suitable copies or extracts therefrom, sufficient to enable
      the Trustee or such paying agent to give any notice by mail that may be required under the provisions of this Section.

     

      

    Section 3.03      Payment Upon Redemption.

     

      

    (a)       If the giving of notice of redemption shall have been completed as above provided, the Securities or portions of Securities of the series to be redeemed specified in such
      notice shall become due and payable on the date and at the place stated in such notice at the applicable redemption price, together with interest accrued to, but excluding, the date fixed for redemption and interest on such Securities or portions of
      Securities shall cease to accrue on and after the date fixed for redemption, unless the Company shall default in the payment of such redemption price and accrued interest with respect to any such Security or portion thereof.  On presentation and
      surrender of such Securities on or after the date fixed for redemption at the place of payment specified in the notice, said Securities shall be paid and redeemed at the applicable redemption price for such series, together with interest accrued
      thereon to, but excluding, the date fixed for redemption (but if the date fixed for redemption is an Interest Payment Date, the interest installment payable on such date shall be payable to the registered holder at the close of business on the
      applicable record date pursuant to Section 2.03).

     

      

    (b)       Upon presentation of any Security of such series that is to be redeemed in part only, the Company shall execute and the Trustee shall authenticate and the office or
      agency where the Security is presented shall deliver to the Securityholder thereof, at the expense of the Company, a new Security of the same series of authorized denominations in principal amount equal to the unredeemed portion of the Security so
      presented.

     

      

    Section 3.04      Sinking Fund.

     

      

    The provisions of Sections 3.04, 3.05 and 3.06 shall be applicable to any sinking fund for the retirement of Securities of a series, except as otherwise specified as contemplated by Section 2.01 for
      Securities of such series.

     

    

    
      17

      
        

    

    The minimum amount of any sinking fund payment provided for by the terms of Securities of any series is herein referred to as a “mandatory sinking fund payment,” and any payment in excess of such
      minimum amount provided for by the terms of Securities of any series is herein referred to as an “optional sinking fund payment”.  If provided for by the terms of Securities of any series, the cash amount of any sinking fund payment may be subject to
      reduction as provided in Section 3.05.  Each sinking fund payment shall be applied to the redemption of Securities of any series as provided for by the terms of Securities of such series.

     

    

    Section 3.05      Satisfaction of Sinking Fund Payments with Securities.

     

    

    The Company (i) may deliver Outstanding Securities of a series and (ii) may apply as a credit Securities of a series that have been redeemed either at the election of the Company pursuant to the
      terms of such Securities or through the application of permitted optional sinking fund payments pursuant to the terms of such Securities, in each case in satisfaction of all or any part of any sinking fund payment with respect to the Securities of
      such series required to be made pursuant to the terms of such Securities as provided for by the terms of such series, provided that such Securities have not been previously so credited.  Such Securities shall be received and credited for such purpose
      by the Trustee at the redemption price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly.

     

    

    Section 3.06      Redemption of Securities for Sinking Fund.

     

      

    Not less than 45 days prior to each sinking fund payment date for any series of Securities (unless a shorter period shall be satisfactory to the Trustee), the Company will deliver to the Trustee an
      Officer’s Certificate specifying the amount of the next ensuing sinking fund payment for that series pursuant to the terms of the series, the portion thereof, if any, that is to be satisfied by delivering and crediting Securities of that series
      pursuant to Section 3.05 and the basis for such credit and will, together with such Officer’s Certificate, deliver to the Trustee any Securities to be so delivered.  Not less than 30 days before each such sinking fund payment date the Securities to
      be redeemed upon such sinking fund payment date shall be selected in the manner specified in Section 3.02 and the Company shall cause notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided
      in Section 3.02.  Such notice having been duly given, the redemption of such Securities shall be made upon the terms and in the manner stated in Section 3.03.

     

    

    ARTICLE 4
      

      

      COVENANTS

     

      

    Section 4.01      Payment of Principal, Premium and Interest.

     

    

    The Company will duly and punctually pay or cause to be paid the principal of (and premium, if any) and interest on the Securities of that series at the time and place and in the manner provided
      herein and established with respect to such Securities. Payments of principal on the Securities may be made at the time provided herein and established with respect to such Securities by U.S. dollar check drawn on and mailed to the address of the
      Securityholder entitled thereto as such address shall appear in the Security Register, or U.S. dollar wire transfer to, a U.S. dollar account if such Securityholder shall have furnished wire instructions to the Trustee no later than 15 days prior to
      the relevant payment date. Payments of interest on the Securities may be made at the time provided herein and established with respect to such Securities by U.S. dollar check mailed to the address of the Securityholder entitled thereto as such
      address shall appear in the Security Register, or U.S. dollar wire transfer to, a U.S. dollar account if such Securityholder shall have furnished wire instructions in writing to the Security Registrar and the Trustee no later than 15 days prior to
      the relevant payment date.

     

    

    
      18

      
        

    

    Section 4.02      Maintenance of Office or Agency.

     

      

    So long as any series of the Securities remain Outstanding, the Company agrees to maintain an office or agency with respect to each such series and at such other location or locations as may be
      designated as provided in this Section 4.02, where (i) Securities of that series may be presented for payment, (ii) Securities of that series may be presented as herein above authorized for registration of transfer and exchange, and (iii) notices and
      demands to or upon the Company in respect of the Securities of that series and this Indenture may be given or served, such designation to continue with respect to such office or agency until the Company shall, by written notice signed by any officer
      authorized to sign an Officer’s Certificate and delivered to the Trustee, designate some other office or agency for such purposes or any of them.  If at any time the Company shall fail to maintain any such required office or agency or shall fail to
      furnish the Trustee with the address thereof, such presentations, notices and demands may be made or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such presentations,
      notices and demands.  The Company initially appoints the Corporate Trust Office of the Trustee as its paying agent with respect to the Securities.

     

    

    Section 4.03      Paying Agents.

     

    

    (a) If the Company shall appoint one or more paying agents for all
      or any series of the Securities, other than the Trustee, the Company will cause each such paying agent to execute and deliver to the Trustee an instrument in which such agent shall agree with the Trustee, subject to the provisions of this Section:

     

      

    (1)        that it will hold all sums held by it as such agent for the
        payment of the principal of (and premium, if any) or interest on the Securities of that series (whether such sums have been paid to it by the Company or by any other obligor of such Securities) in trust for the benefit of the Persons entitled
        thereto;

     

      

    (2)        that it will give the Trustee notice of any failure by the Company
        (or by any other obligor of such Securities) to make any payment of the principal of (and premium, if any) or interest on the Securities of that series when the same shall be due and payable;

     

      

    (3)        that it will, at any time during the continuance of any failure
        referred to in the preceding paragraph (a)(2) above, upon the written request of the Trustee, forthwith pay to the Trustee all sums so held in trust by such paying agent; and

     

      

    
      19

      
        

    

    (4)        that it will perform all other duties of paying agent as set forth
        in this Indenture.

     

      

    (b)       If the Company shall act as its own paying agent with respect to any series of the Securities, it will on or before each due date of the principal of (and premium, if
      any) or interest on Securities of that series, set aside, segregate and hold in trust for the benefit of the Persons entitled thereto a sum sufficient to pay such principal (and premium, if any) or interest so becoming due on Securities of that
      series until such sums shall be paid to such Persons or otherwise disposed of as herein provided and will promptly notify the Trustee of such action, or any failure (by it or any other obligor on such Securities) to take such action.  Whenever the
      Company shall have one or more paying agents for any series of Securities, it will, prior to each due date of the principal of (and premium, if any) or interest on any Securities of that series, deposit with the paying agent a sum sufficient to pay
      the principal (and premium, if any) or interest so becoming due, such sum to be held in trust for the benefit of the Persons entitled to such principal, premium or interest, and (unless such paying agent is the Trustee) the Company will promptly
      notify the Trustee of this action or failure so to act.

     

      

    (c)        Notwithstanding anything in this Section to the contrary, (i) the agreement to hold sums in trust as provided in this Section is subject to the provisions of Section
      11.05, and (ii) the Company may at any time, for the purpose of obtaining the satisfaction and discharge of this Indenture or for any other purpose, pay, or direct any paying agent to pay, to the Trustee all sums held in trust by the Company or such
      paying agent, such sums to be held by the Trustee upon the same terms and conditions as those upon which such sums were held by the Company or such paying agent; and, upon such payment by the Company or any paying agent to the Trustee, the Company or
      such paying agent shall be released from all further liability with respect to such money.

     

      

    Section 4.04      Appointment to Fill Vacancy in Office of Trustee.

     

      

    The Company, whenever necessary to avoid or fill a vacancy in the office of Trustee, will appoint, in the manner provided in Section 7.10, a Trustee, so that there shall at all times be a Trustee
      hereunder.

    

    

    

    

    

    ARTICLE 5

    

    

    SECURITYHOLDERS’ LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE

    

    

    Section 5.01      Company to Furnish Trustee Names and Addresses of Securityholders.

    

    

    The Company will furnish or cause to be furnished to the Trustee (a) within 15 days after each regular record date (as defined in Section 2.03) a list, in such form as the Trustee may reasonably
      require, of the names and addresses of the holders of each series of Securities as of such regular record date, provided that the Company shall not be obligated to furnish or cause to furnish such list at any time that the list shall not differ in
      any respect from the most recent list furnished to the Trustee by the Company and (b) at such other times as the Trustee may request in writing within 30 days after the receipt by the Company of any such request, a list of similar form and content as
      of a date not more than 15 days prior to the time such list is furnished; provided, however, that, in either case, no such list need be furnished for any series for which the Trustee shall be the Security Registrar.

    

    

    
      20

      
        

    

    Section 5.02      Preservation Of Information; Communications With Securityholders.

    

    

    (a)       The Trustee shall preserve, in as current a form as is reasonably practicable, all information as to the names and addresses of the holders of
      Securities contained in the most recent list furnished to it as provided in Section 5.01 and as to the names and addresses of holders of Securities received by the Trustee in its capacity as Security Registrar (if acting in such capacity).

    

    

    (b)       The Trustee may destroy any list furnished to it as provided in Section 5.01 upon receipt of a new list so furnished.

    

    

    (c)       Securityholders may communicate as provided in Section 312(b) of the Trust Indenture Act with other Securityholders with respect to their rights
      under this Indenture or under the Securities, and, in connection with any such communications, the Trustee shall satisfy its obligations under Section 312(b) of the Trust Indenture Act in accordance with the provisions of Section 312(b) of the Trust
      Indenture Act.

    

    

    Section 5.03      Reports by the Company.

    

    

    (a)       The Company will at all times comply with Section 314(a) of the Trust Indenture Act.  The Company covenants and agrees to provide (which delivery may
      be via electronic mail) to the Trustee within 30 days, after the Company files the same with the Commission, copies of the annual reports and of the information, documents and other reports (or copies of such portions of any of the foregoing as the
      Commission may from time to time by rules and regulations prescribe) that the Company is required to file with the Commission pursuant to Section 13 or Section 15(d) of the Exchange Act; provided, however, the Company shall not be required to deliver
      to the Trustee any correspondence filed with the Commission or any materials for which the Company has sought and received confidential treatment by the Commission; and provided further, that so long as such filings by the Company are available on
      the Commission’s Electronic Data Gathering, Analysis and Retrieval System (EDGAR), or any successor system, such filings shall be deemed to have been filed with the Trustee for purposes hereof without any further action required by the Company. For
      the avoidance of doubt, a failure by the Company to file annual reports, information and other reports with the Commission within the time period prescribed thereof by the Commission shall not be deemed a breach of this Section 5.03.

    

    

    (b)       Delivery of reports, information and documents to the Trustee under Section 5.03 is for informational purposes only and the information and the
      Trustee’s receipt of the foregoing shall not constitute constructive notice of any information contained therein, or determinable from information contained therein including the Company’s compliance with any of their covenants thereunder (as to
      which the Trustee is entitled to rely exclusively on an Officer’s Certificate).  The Trustee is under no duty to examine any such reports, information or documents delivered to the Trustee or filed with the Commission via EDGAR to ensure compliance
      with the provision of this Indenture or to ascertain the correctness or otherwise of the information or the statements contained therein.  The Trustee shall have no responsibility or duty whatsoever to ascertain or determine whether the above
      referenced filings with the Commission on EDGAR (or any successor system) has occurred.

    

    

    
      21

      
        

    

    Section 5.04      Reports by the Trustee.

    

    

    (a)     If required by Section 313(a) of the Trust Indenture Act, the Trustee, within sixty (60) days after each May 1, shall send to the Securityholders a
      brief report dated as of such May 1, which complies with Section 313(a) of the Trust Indenture Act.

    

    

    (b)       The Trustee shall comply with Section 313(b) and 313(c) of the Trust Indenture Act.

    

    

    (c)       A copy of each such report shall, at the time of such transmission to Securityholders, be filed by the Trustee with the Company, with each securities
      exchange upon which any Securities are listed (if so listed) and also with the Commission.  The Company agrees to notify the Trustee when any Securities become listed on any securities exchange.

     

      

    ARTICLE 6

    

    

    REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT

    

    

    Section 6.01      Events of Default.

    

    

    (a)       Whenever used herein with respect to Securities of a particular series, “Event of Default” means any one or more of the following events that has
      occurred and is continuing:

    

    

    (1)       the Company defaults in the payment of any
        installment of interest upon any of the Securities of that series, as and when the same shall become due and payable, and such default continues for a period of 90 days; provided, however, that a valid extension of an interest payment period by the
        Company in accordance with the terms of any indenture supplemental hereto shall not constitute a default in the payment of interest for this purpose;

    

    

    (2)        the Company defaults in the payment of the
        principal of (or premium, if any, on) any of the Securities of that series as and when the same shall become due and payable whether at maturity, upon redemption, by declaration or otherwise, or in any payment required by any sinking or analogous
        fund established with respect to that series; provided, however, that a valid extension of the maturity of such Securities in accordance with the terms of any indenture supplemental hereto shall not constitute a default in the payment of principal
        or premium, if any;

    

    

    
      22

      
        

    

    (3)       the Company fails to observe or perform any
        other of its covenants or agreements with respect to that series contained in this Indenture or otherwise established with respect to that series of Securities pursuant to Section 2.01 hereof (other than a covenant or agreement that has been
        expressly included in this Indenture solely for the benefit of one or more series of Securities other than such series) for a period of 90 days after the date on which written notice of such failure, requiring the same to be remedied and stating
        that such notice is a “Notice of Default” hereunder, shall have been given to the Company by the Trustee, by registered or certified mail, or to the Company and the Trustee by the holders of at least 25% in principal amount of the Securities of
        that series at the time Outstanding;

    

    

    (4)       the Company pursuant to or within the meaning
        of any Bankruptcy Law (i) commences a voluntary case, (ii) consents to the entry of an order for relief against it in an involuntary case, (iii) consents to the appointment of a Custodian of it or for all or substantially all of its property or
        (iv) makes a general assignment for the benefit of its creditors; or

    

    

    (5)      a court of competent jurisdiction enters an
        order under any Bankruptcy Law that (i) is for relief against the Company in an involuntary case, (ii) appoints a Custodian of the Company for all or substantially all of its property or (iii) orders the liquidation of the Company, and the order or
        decree remains unstayed and in effect for 90 days.

    

    

    (b)      In each and every such case (other than an Event of Default specified in clause (4) or clause (5) above), unless the principal of all the Securities
      of that series shall have already become due and payable, either the Trustee or the holders of not less than 25% in aggregate principal amount of the Securities of that series then Outstanding hereunder, by notice in writing to the Company (and to
      the Trustee if given by such Securityholders), may declare the principal of (and premium, if any, on) and accrued and unpaid interest on all the Securities of that series to be due and payable immediately, and upon any such declaration the same shall
      become and shall be immediately due and payable.  If an Event of Default specified in clause (4) or clause (5) above occurs, the principal of and accrued and unpaid interest on all the Securities of that series shall automatically be immediately due
      and payable without any declaration or other act on the part of the Trustee or the holders of the Securities.

    

    

    (c)       At any time after the principal of (and premium, if any, on) and accrued and unpaid interest on the Securities of that series shall have been so
      declared due and payable, and before any judgment or decree for the payment of the moneys due shall have been obtained or entered as hereinafter provided, the holders of a majority in aggregate principal amount of the Securities of that series then
      Outstanding hereunder, by written notice to the Company and the Trustee, may rescind and annul such declaration and its consequences if: (i) the Company has paid or deposited with the Trustee a sum sufficient to pay all matured installments of
      interest upon all the Securities of that series and the principal of (and premium, if any, on) any and all Securities of that series that shall have become due otherwise than by acceleration (with interest upon such principal and premium, if any,
      and, to the extent that such payment is enforceable under applicable law, upon overdue installments of interest, at the rate per annum expressed in the Securities of that series to the date of such payment or deposit) and the amount payable to the
      Trustee under Section 7.06, and (ii) any and all Events of Default under the Indenture with respect to such series, other than the nonpayment of principal on (and premium, if any, on) and accrued and unpaid interest on Securities of that series that
      shall not have become due by their terms, shall have been remedied or waived as provided in Section 6.06.

    

    

    
      23

      
        

    

    No such rescission and annulment shall extend to or shall affect any subsequent default or impair any right consequent thereon.

    

    

    (d)      In case the Trustee shall have proceeded to enforce any right with respect to Securities of that series under this Indenture and such proceedings
      shall have been discontinued or abandoned because of such rescission or annulment or for any other reason or shall have been determined adversely to the Trustee, then and in every such case, subject to any determination in such proceedings, the
      Company and the Trustee shall be restored respectively to their former positions and rights hereunder, and all rights, remedies and powers of the Company and the Trustee shall continue as though no such proceedings had been taken.

    

    

    Section 6.02      Collection of Indebtedness and Suits for Enforcement by Trustee.

    

    

    (a)       The Company covenants that (i) in case it shall default in the payment of any installment of interest on any of the Securities of a series, or in any
      payment required by any sinking or analogous fund established with respect to that series as and when the same shall have become due and payable, and such default shall have continued for a period of 90 days, or (ii) in case it shall default in the
      payment of the principal of (or premium, if any, on) any of the Securities of a series when the same shall have become due and payable, whether upon maturity of the Securities of a series or upon redemption or upon declaration or otherwise then, upon
      demand of the Trustee, the Company will pay to the Trustee, for the benefit of the holders of the Securities of that series, the whole amount that then shall have been become due and payable on all such Securities for principal (and premium, if any)
      or interest, or both, as the case may be, with interest upon the overdue principal (and premium, if any) and (to the extent that payment of such interest is enforceable under applicable law) upon overdue installments of interest at the rate per annum
      expressed in the Securities of that series; and, in addition thereto, such further amount as shall be sufficient to cover the costs and expenses of collection, and the amount payable to the Trustee under Section 7.06.

    

    

    (b)      If the Company shall fail to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an express trust, shall be
      entitled and empowered to institute any action or proceedings at law or in equity for the collection of the sums so due and unpaid, and may prosecute any such action or proceeding to judgment or final decree, and may enforce any such judgment or
      final decree against the Company or other obligor upon the Securities of that series and collect the moneys adjudged or decreed to be payable in the manner provided by law or equity out of the property of the Company or other obligor upon the
      Securities of that series, wherever situated.

    

    

    
      24

      
        

    

    (c)     In case of any receivership, insolvency, liquidation, bankruptcy, reorganization, readjustment, arrangement, composition or judicial proceedings
      affecting the Company, or its creditors or property, the Trustee shall have power to intervene in such proceedings and take any action therein that may be permitted by the court and shall (except as may be otherwise provided by law) be entitled to
      file such proofs of claim and other papers and documents as may be necessary or advisable in order to have the claims of the Trustee and of the holders of Securities of such series allowed for the entire amount due and payable by the Company under
      the Indenture at the date of institution of such proceedings and for any additional amount that may become due and payable by the Company after such date, and to collect and receive any moneys or other property payable or deliverable on any such
      claim, and to distribute the same after the deduction of the amount payable to the Trustee under Section 7.06; and any receiver, assignee or trustee in bankruptcy or reorganization is hereby authorized by each of the holders of Securities of such
      series to make such payments to the Trustee, and, in the event that the Trustee shall consent to the making of such payments directly to such Securityholders, to pay to the Trustee any amount due it under Section 7.06.

    

    

    (d)       All rights of action and of asserting claims under this Indenture, or under any of the terms established with respect to Securities of that series,
      may be enforced by the Trustee without the possession of any of such Securities, or the production thereof at any trial or other proceeding relative thereto, and any such suit or proceeding instituted by the Trustee shall be brought in its own name
      as trustee of an express trust, and any recovery of judgment shall, after provision for payment to the Trustee of any amounts due under Section 7.06, be for the ratable benefit of the holders of the Securities of such series.

    

    

    In case of an Event of Default hereunder, the Trustee may in its discretion proceed to protect and enforce the rights vested in it by this Indenture by such appropriate judicial proceedings as the
      Trustee shall deem most effectual to protect and enforce any of such rights, either at law or in equity or in bankruptcy or otherwise, whether for the specific enforcement of any covenant or agreement contained in the Indenture or in aid of the
      exercise of any power granted in this Indenture, or to enforce any other legal or equitable right vested in the Trustee by this Indenture or by law.

    

    

    Nothing contained herein shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Securityholder any plan of reorganization, arrangement, adjustment or
      composition affecting the Securities of that series or the rights of any Securityholder thereof or to authorize the Trustee to vote in respect of the claim of any Securityholder in any such proceeding.

    

    

    Section 6.03      Application of Moneys Collected.

    

    

    Any moneys collected by the Trustee pursuant to this Article with respect to a particular series of Securities shall be applied in the following order, at the date or dates fixed by the Trustee and,
      in case of the distribution of such moneys on account of principal (or premium, if any) or interest, upon presentation of the Securities of that series, and notation thereon of the payment, if only partially paid, and upon surrender thereof if fully
      paid:

    

    

    FIRST: To the payment of costs and expenses of collection and of all amounts payable to the Trustee under Section 7.06;

    

    

    SECOND: To the payment of the amounts then due and unpaid upon Securities of such series for principal (and premium, if any) and interest, in respect of which or for the benefit of which such money
      has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Securities for principal (and premium, if any) and interest, respectively; and

    

    

    
      25

      
        

    

    THIRD: To the payment of the remainder, if any, to the Company or any other Person lawfully entitled thereto.

    

    

    Section 6.04      Limitation on Suits.

    

    

    No holder of any Security of any series shall have any right by virtue or by availing of any provision of this Indenture to institute any suit, action or proceeding in equity or at law upon or under
      or with respect to this Indenture or for the appointment of a receiver or trustee, or for any other remedy hereunder, unless (i) such Securityholder previously shall have given to the Trustee written notice of an Event of Default and of the
      continuance thereof with respect to the Securities of such series specifying such Event of Default, as hereinbefore provided; (ii) the holders of not less than 25% in aggregate principal amount of the Securities of such series then Outstanding shall
      have made written request upon the Trustee to institute such action, suit or proceeding in its own name as Trustee hereunder; (iii) such Securityholder or Securityholders shall have offered to the Trustee indemnity satisfactory to it against the
      costs, expenses and liabilities to be incurred in compliance with such request; (iv) the Trustee for 90 days after its receipt of such notice, request and offer of indemnity, shall have failed to institute any such action, suit or proceeding and (v)
      during such 90 day period, the holders of a majority in principal amount of the Securities of that series do not give the Trustee a direction inconsistent with the request.

    

    

    Notwithstanding anything contained herein to the contrary or any other provisions of this Indenture, the right of any holder of any Security to receive payment of the principal of (and premium, if
      any) and interest on such Security, as therein provided, on or after the respective due dates expressed in such Security (or in the case of redemption, on the redemption date), or to institute suit for the enforcement of any such payment on or after
      such respective dates or redemption date, shall not be impaired or affected without the consent of such holder and by accepting a Security hereunder it is expressly understood, intended and covenanted by the taker and holder of every Security of such
      series with every other such taker and holder and the Trustee, that no one or more holders of Securities of such series shall have any right in any manner whatsoever by virtue or by availing of any provision of this Indenture to affect, disturb or
      prejudice the rights of the holders of any other of such Securities, or to obtain or seek to obtain priority over or preference to any other such holder, or to enforce any right under this Indenture, except in the manner herein provided and for the
      equal, ratable and common benefit of all holders of Securities of such series.  For the protection and enforcement of the provisions of this Section, each and every Securityholder and the Trustee shall be entitled to such relief as can be given
      either at law or in equity.

    

    

    Section 6.05      Rights and Remedies Cumulative; Delay or Omission Not Waiver.

    

    

    (a)       Except as otherwise provided in Section 2.07, all powers and remedies given by this Article to the Trustee or to the Securityholders shall, to the
      extent permitted by law, be deemed cumulative and not exclusive of any other powers and remedies available to the Trustee or the holders of the Securities, by judicial proceedings or otherwise, to enforce the performance or observance of the
      covenants and agreements contained in this Indenture or otherwise established with respect to such Securities.

    

    

    
      26

      
        

    

    (b)       No delay or omission of the Trustee or of any holder of any of the Securities to exercise any right or power accruing upon any Event of Default
      occurring and continuing as aforesaid shall impair any such right or power, or shall be construed to be a waiver of any such default or an acquiescence therein; and, subject to the provisions of Section 6.04, every power and remedy given by this
      Article or by law to the Trustee or the Securityholders may be exercised from time to time, and as often as shall be deemed expedient, by the Trustee or by the Securityholders.

    

    

    Section 6.06      Control by Securityholders.

    

    

    The holders of a majority in aggregate principal amount of the Securities of any series at the time Outstanding, determined in accordance with Section 8.04, shall have the right to direct the time,
      method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee with respect to such series; provided, however, that such direction shall not be in conflict with any
      rule of law or with this Indenture or subject the Trustee in its sole discretion to personal liability.  Subject to the provisions of Section 7.01, the Trustee shall have the right to decline to follow any such direction if the Trustee in good faith
      shall, by a Responsible Officer or officers of the Trustee, determine that the proceeding so directed, subject to the Trustee’s duties under the Trust Indenture Act, would involve the Trustee in personal liability or might be unduly prejudicial to
      the Securityholders not involved in the proceeding.  The holders of a majority in aggregate principal amount of the Securities of any series at the time Outstanding affected thereby, determined in accordance with Section 8.04, may on behalf of the
      holders of all of the Securities of such series waive any past default in the performance of any of the covenants contained herein or established pursuant to Section 2.01 with respect to such series and its consequences, except a default in the
      payment of the principal of, or premium, if any, or interest on, any of the Securities of that series as and when the same shall become due by the terms of such Securities otherwise than by acceleration (unless such default has been cured and a sum
      sufficient to pay all matured installments of interest and principal and any premium has been deposited with the Trustee (in accordance with Section 6.01(c)).  Upon any such waiver, the default covered thereby shall be deemed to be cured for all
      purposes of this Indenture and the Company, the Trustee and the holders of the Securities of such series shall be restored to their former positions and rights hereunder, respectively; but no such waiver shall extend to any subsequent or other
      default or impair any right consequent thereon.

    

    

    Section 6.07      Undertaking to Pay Costs.

    

    

    All parties to this Indenture agree, and each holder of any Securities by such holder’s acceptance thereof shall be deemed to have agreed, that any court may in its discretion require, in any suit
      for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and
      that such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party
      litigant; but the provisions of this Section shall not apply to any suit instituted by the Trustee, to any suit instituted by any Securityholder, or group of Securityholders, holding more than 10% in aggregate principal amount of the Outstanding
      Securities of any series, or to any suit instituted by any Securityholder for the enforcement of the payment of the principal of (or premium, if any) or interest on any Security of such series, on or after the respective due dates expressed in such
      Security or established pursuant to this Indenture.

    

    

    
      27

      
        

    

    ARTICLE 7

    

    

    CONCERNING THE TRUSTEE

    

    

    Section 7.01      Certain Duties and Responsibilities of Trustee.

    

    

    (a)       The Trustee, prior to the occurrence of an Event of Default with respect to the Securities of a series and after the curing of all Events of Default
      with respect to the Securities of that series that may have occurred, shall undertake to perform with respect to the Securities of such series such duties and only such duties as are specifically set forth in this Indenture, and no implied covenants
      shall be read into this Indenture against the Trustee.  In case an Event of Default with respect to the Securities of a series has occurred (that has not been cured or waived), the Trustee shall exercise with respect to Securities of that series such
      of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in the conduct of his or her own affairs.

    

    

    (b)      No provision of this Indenture shall be construed to relieve the Trustee from liability for its own negligent action, its own negligent failure to
      act, or its own willful misconduct, except that:

    

    

    (i)          prior to the occurrence of an Event of Default with respect to the Securities of a series and after the curing or waiving of all such Events of
      Default with respect to that series that may have occurred:

    

    

    (A)      the duties and obligations of the Trustee shall
        with respect to the Securities of such series be determined solely by the express provisions of this Indenture, and the Trustee shall not be liable with respect to the Securities of such series except for the performance of such duties and
        obligations as are specifically set forth in this Indenture, and no implied covenants or obligations shall be read into this Indenture against the Trustee; and

    

    

    (B)       in the absence of bad faith on the part of the
        Trustee, the Trustee may with respect to the Securities of such series conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon any certificates or opinions furnished to the Trustee and
        conforming to the requirements of this Indenture; but in the case of any such certificates or opinions that by any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to
        determine whether or not they conform to the requirements of this Indenture;

    

    

    
      28

      
        

    

    (ii)       the Trustee shall not be liable to any Securityholder or to any other Person for any error of judgment made in good faith by a Responsible Officer
      or Responsible Officers of the Trustee, unless it shall be proved that the Trustee was negligent in ascertaining the pertinent facts;

    

    

    (iii)        the Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of
      the holders of not less than a majority in principal amount of the Securities of any series at the time Outstanding relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust
      or power conferred upon the Trustee under this Indenture with respect to the Securities of that series;

    

    

    (iv)        none of the provisions contained in this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur personal financial
      liability in the performance of any of its duties or in the exercise of any of its rights or powers if there is reasonable ground for believing that the repayment of such funds or liability is not reasonably assured to it under the terms of this
      Indenture or adequate indemnity against such risk is not reasonably assured to it;

    

    

    (v)          The Trustee shall not be required to give any bond or surety in respect of the performance of its powers or duties hereunder;

    

    

    (vi)         The permissive right of the Trustee to do things enumerated in this Indenture shall not be construed as a duty of the Trustee; and

    

    

    (vii)       No Trustee shall have any duty or responsibility for any act or omission of any other Trustee appointed with respect to a series of Securities
      hereunder.

    

    

    Section 7.02      Certain Rights of Trustee.

    

    

    Except as otherwise provided in Section 7.01:

    

    

    (a)       The Trustee may conclusively rely and shall be protected in acting or refraining from acting upon any resolution, certificate, statement, instrument,
      opinion, report, notice, request, consent, order, approval, bond, security or other paper or document believed by it to be genuine and to have been signed or presented by the proper party or parties;

    

    

    (b)      Any request, direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by a Board Resolution or an instrument signed
      in the name of the Company by any authorized Officer of the Company (unless other evidence in respect thereof is specifically prescribed herein);

    

    

    (c)       The Trustee may consult with counsel and the opinion or written advice of such counsel or, if requested, any Opinion of Counsel shall be full and
      complete authorization and protection in respect of any action taken or suffered or omitted hereunder in good faith and in reliance thereon;

    

    

    
      29

      
        

    

    (d)      The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request, order or direction of
      any of the Securityholders pursuant to the provisions of this Indenture, unless such Securityholders shall have offered to the Trustee security or indemnity reasonably acceptable to the Trustee against the costs, expenses and liabilities that may be
      incurred therein or thereby; nothing contained herein shall, however, relieve the Trustee of the obligation, upon the occurrence of an Event of Default with respect to a series of the Securities (that has not been cured or waived), to exercise with
      respect to Securities of that series such of the rights and powers vested in it by this Indenture, and to use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in the conduct of his or
      her own affairs;

    

    

    (e)       The Trustee shall not be liable for any action taken or omitted to be taken by it in good faith and believed by it to be authorized or within the
      discretion or rights or powers conferred upon it by this Indenture;

    

    

    (f)      The Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument,
      opinion, report, notice, request, consent, order, approval, bond, security, or other papers or documents or inquire as to the performance by the Company of one of its covenants under this Indenture, unless requested in writing so to do by the holders
      of not less than a majority in principal amount of the Outstanding Securities of the particular series affected thereby (determined as provided in Section 8.04); provided, however, that if the payment within a reasonable time to the Trustee of the
      costs, expenses or liabilities likely to be incurred by it in the making of such investigation is, in the opinion of the Trustee, not reasonably assured to the Trustee by the security afforded to it by the terms of this Indenture, the Trustee may
      require security or indemnity reasonably acceptable to the Trustee against such costs, expenses or liabilities as a condition to so proceeding.  The reasonable expense of every such examination shall be paid by the Company or, if paid by the Trustee,
      shall be repaid by the Company upon demand;

    

    

    (g)       The Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys
      and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed with due care by it hereunder;

    

    

    (h)       In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or
      caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and
      interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Trustee shall use reasonable efforts which are consistent with accepted practices in the banking industry to
      resume performance as soon as practicable under the circumstances;

    

    

    (i)       In no event shall the Trustee be responsible or liable for special, indirect, punitive or consequential loss or damage of any kind whatsoever
      (including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action;

    

    

    
      30

      
        

    

    (j)      The Trustee agrees to accept and act upon instructions or directions pursuant to this Indenture sent by unsecured e-mail, facsimile transmission or
      other similar unsecured electronic methods; provided, however, that such instructions or directions shall be signed by an authorized representative of the party providing such instructions or directions.  If the party elects to give the Trustee
      e-mail or facsimile instructions (or instructions by a similar electronic method) and the Trustee in its discretion elects to act upon such instructions, the Trustee’s understanding of such instructions shall be deemed controlling.  The Trustee shall
      not be liable for any losses, costs or expenses arising directly or indirectly from the Trustee’s reliance upon and compliance with such instructions notwithstanding such instructions conflict or are inconsistent with a subsequent written
      instruction.  The party providing electronic instructions agrees to assume all risks arising out of the use of such electronic methods to submit instructions and directions to the Trustee, including without limitation the risk of the Trustee acting
      on unauthorized instructions, and the risk or interception and misuse by third parties.  The Trustee may request that the Company deliver an Officer’s Certificate setting forth the names of individuals and/or titles of officers authorized at such
      time to furnish the Trustee with Officer’s Certificates, Company Orders and any other matters or directions pursuant to this Indenture;

    

    

    (k)       The rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are
      extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder and under the Securities, and each agent, custodian or other person employed to act under this Indenture; and

    

    

    (l)        The Trustee shall not be deemed to have knowledge of any Default or Event of Default (other than an Event of Default constituting the failure to pay
      the interest on, or the principal of, the Securities if the Trustee also serves as the paying agent for such Securities) until the Trustee shall have received written notification in the manner set forth in this Indenture or a Responsible Officer of
      the Trustee shall have obtained actual knowledge.

    

    

    Section 7.03      Trustee Not Responsible for Recitals or Issuance or Securities.

    

    

    (a)     The recitals contained herein and in the Securities shall be taken as the statements of the Company, and the Trustee assumes no responsibility for the
      correctness of the same.  The Trustee shall not be responsible for any statement in any registration statement, prospectus, or any other document in connection with the sale of Securities. The Trustee shall not be responsible for any rating on the
      Securities or any action or omission of any rating agency.

    

    

    (b)       The Trustee makes no representations as to the validity or sufficiency of this Indenture or of the Securities.

    

    

    (c)      The Trustee shall not be accountable for the use or application by the Company of any of the Securities or of the proceeds of such Securities, or for
      the use or application of any moneys paid over by the Trustee in accordance with any provision of this Indenture or established pursuant to Section 2.01, or for the use or application of any moneys received by any paying agent other than the Trustee.

    

    

    
      31

      
        

    

    Section 7.04      May Hold Securities.

    

    

    The Trustee or any paying agent or Security Registrar, in its individual or any other capacity, may become the owner or pledgee of Securities with the same rights it would have if it were not
      Trustee, paying agent or Security Registrar.

    

    

    Section 7.05      Moneys Held in Trust.

    

    

    Subject to the provisions of Section 11.05, all moneys received by the Trustee shall, until used or applied as herein provided, be held in trust for the purposes for which they were received, but
      need not be segregated from other funds except to the extent required by law.  The Trustee shall be under no liability for interest on any moneys received by it hereunder except such as it may agree with the Company to pay thereon.

    

    

    Section 7.06      Compensation and Reimbursement.

    

    

    (a)      The Company shall pay to the Trustee for each of its capacities hereunder from time to time compensation for its services as the Company and the
      Trustee shall from time to time agree upon in writing.  The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust.  The Company shall reimburse the Trustee upon request for all reasonable
      out-of-pocket expenses incurred by it.  Such expenses shall include the reasonable compensation and expenses of the Trustee’s agents and counsel.

    

    

    (b)       The Company shall indemnify each of the Trustee in each of its capacities hereunder against any loss, liability or expense (including the cost of
      defending itself and including the reasonable compensation and expenses of the Trustee’s agents and counsel) incurred by it except as set forth in Section 7.06(c) in the exercise or performance of its powers, rights or duties under this Indenture as
      Trustee or Agent.  The Trustee shall notify the Company promptly of any claim for which it may seek indemnity.  The Company shall defend the claim and the Trustee shall cooperate in the defense.  The Trustee may have one separate counsel and the
      Company shall pay the reasonable fees and expenses of such counsel.  The Company need not pay for any settlement made without its consent, which consent shall not be unreasonably withheld.  This indemnification shall apply to officers, directors,
      employees, shareholders and agents of the Trustee.

    

    

    (c)      The Company need not reimburse any expense or indemnify against any loss or liability incurred by the Trustee or by any officer, director, employee,
      shareholder or agent of the Trustee through negligence or bad faith.

    

    

    (d)       To ensure the Company’s payment obligations in this Section, the Trustee shall have a lien prior to the Securities on all funds or property held or
      collected by the Trustee, except that held in trust to pay principal of or interest on particular Securities.  When the Trustee incurs expenses or renders services in connection with an Event of Default specified in Section 6.01(4) or (5), the
      expenses (including the reasonable fees and expenses of its counsel) and the compensation for services in connection therewith are to constitute expenses of administration under any bankruptcy law.  The provisions of this Section 7.06 shall survive
      the termination of this Indenture and the resignation or removal of the Trustee.

    

    

    
      32

      
        

    

    Section 7.07      Reliance on Officer’s Certificate.

    

    

    Except as otherwise provided in Section 7.01, whenever in the administration of the provisions of this Indenture the Trustee shall deem it reasonably necessary or desirable that a matter be proved or
      established prior to taking or suffering or omitting to take any action hereunder, such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in the absence of negligence or bad faith on the part of the Trustee, be
      deemed to be conclusively proved and established by an Officer’s Certificate delivered to the Trustee and such certificate, in the absence of negligence or bad faith on the part of the Trustee, shall be full warrant to the Trustee for any action
      taken, suffered or omitted to be taken by it under the provisions of this Indenture upon the faith thereof.

    

    

    Section 7.08      Disqualification; Conflicting Interests.

    

    

    If the Trustee has or shall acquire any “conflicting interest” within the meaning of Section 310(b) of the Trust Indenture Act, the Trustee and the Company shall in all respects comply with the
      provisions of Section 310(b) of the Trust Indenture Act.

    

    

    Section 7.09      Corporate Trustee Required; Eligibility.

    

    

    There shall at all times be a Trustee with respect to the Securities issued hereunder which shall at all times be a corporation organized and doing business under the laws of the United States of
      America or any state or territory thereof or of the District of Columbia, or a corporation or other Person permitted to act as trustee by the Commission, authorized under such laws to exercise corporate trust powers, having a combined capital and
      surplus of at least fifty million U.S. dollars ($50,000,000), and subject to supervision or examination by federal, state, territorial, or District of Columbia authority.

    

    

    If such corporation or other Person publishes reports of condition at least annually, pursuant to law or to the requirements of the aforesaid supervising or examining authority, then for the purposes
      of this Section, the combined capital and surplus of such corporation or other Person shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published.  The Company may not, nor may any Person
      directly or indirectly controlling, controlled by, or under common control with the Company, serve as Trustee.  In case at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section, the Trustee shall resign
      immediately in the manner and with the effect specified in Section 7.10.

    

    

    Section 7.10      Resignation and Removal; Appointment of Successor.

    

    

    (a)       The Trustee or any successor hereafter appointed may at any time resign with respect to the Securities of one or more series by giving written notice
      thereof to the Company and the Securityholders of such series.  Upon receiving such notice of resignation, the Company shall promptly appoint a successor trustee with respect to Securities of such series by written instrument, in duplicate, executed
      by order of the Board of Directors, one copy of which instrument shall be delivered to the resigning Trustee and one copy to the successor trustee.  If no successor trustee shall have been so appointed and have accepted appointment within 30 days
      after the sending of such notice of resignation, the resigning Trustee may petition any court of competent jurisdiction for the appointment of a successor trustee with respect to Securities of such series, or any Securityholder of that series who has
      been a bona fide holder of a Security or Securities for at least six months may on behalf of himself and all others similarly situated, petition any such court for the appointment of a successor trustee.  Such court may thereupon after such notice,
      if any, as it may deem proper and prescribe, appoint a successor trustee.

    

    

    
      33

      
        

    

    (b)       In case at any time any one of the following shall occur:

    

    

    (i)       the Trustee shall fail to comply with the
        provisions of Section 7.08 after written request therefor by the Company or by any Securityholder who has been a bona fide holder of a Security or Securities for at least six months; or

    

    

    (ii)        the Trustee shall cease to be eligible in
        accordance with the provisions of Section 7.09 and shall fail to resign after written request therefor by the Company or by any such Securityholder; or

    

    

    (iii)       the Trustee shall become incapable of
        acting, or shall be adjudged a bankrupt or insolvent, or commence a voluntary bankruptcy proceeding, or a receiver of the Trustee or of its property shall be appointed or consented to, or any public officer shall take charge or control of the
        Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation;

    

    

    then, in any such case, the Company may remove the Trustee with respect to all Securities and appoint a successor trustee by written instrument, in duplicate, executed by order of the Board of
      Directors, one copy of which instrument shall be delivered to the Trustee so removed and one copy to the successor trustee, or any Securityholder who has been a bona fide holder of a Security or Securities for at least six months may, on behalf of
      that holder and all others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor trustee.  Such court may thereupon after such notice, if any, as it may deem proper and
      prescribe, remove the Trustee and appoint a successor trustee.

    

    

    (c)       The holders of a majority in aggregate principal amount of the Securities of any series at the time Outstanding may at any time remove the Trustee
      with respect to such series by so notifying the Trustee and the Company and may appoint a successor Trustee for such series with the consent of the Company.

    

    

    (d)       Any resignation or removal of the Trustee and appointment of a successor trustee with respect to the Securities of a series pursuant to any of the
      provisions of this Section shall become effective upon acceptance of appointment by the successor trustee as provided in Section 7.11.

    

    

    (e)       Any successor trustee appointed pursuant to this Section may be appointed with respect to the Securities of one or more series or all of such series,
      and at any time there shall be only one Trustee with respect to the Securities of any particular series.

    

    

    
      34

      
        

    

    Section 7.11      Acceptance of Appointment By Successor.

    

    

    (a)       In case of the appointment hereunder of a successor trustee with respect to all Securities, every such successor trustee so appointed shall execute,
      acknowledge and deliver to the Company and to the retiring Trustee an instrument accepting such appointment, and thereupon the resignation or removal of the retiring Trustee shall become effective and such successor trustee, without any further act,
      deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Trustee; but, on the request of the Company or the successor trustee, such retiring Trustee shall, upon payment of any amounts due to it pursuant
      to the provisions of Section 7.06, execute and deliver an instrument transferring to such successor trustee all the rights, powers, and trusts of the retiring Trustee and shall duly assign, transfer and deliver to such successor trustee all property
      and money held by such retiring Trustee hereunder.

    

    

    (b)      In case of the appointment hereunder of a successor trustee with respect to the Securities of one or more (but not all) series, the Company, the
      retiring Trustee and each successor trustee with respect to the Securities of one or more series shall execute and deliver an indenture supplemental hereto wherein each successor trustee shall accept such appointment and which (i) shall contain such
      provisions as shall be necessary or desirable to transfer and confirm to, and to vest in, each successor trustee all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those series to which the
      appointment of such successor trustee relates, (ii) shall contain such provisions as shall be deemed necessary or desirable to confirm that all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or
      those series as to which the retiring Trustee is not retiring shall continue to be vested in the retiring Trustee, and (iii) shall add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the
      administration of the trusts hereunder by more than one Trustee, it being understood that nothing herein or in such supplemental indenture shall constitute such Trustees co-trustees of the same trust, that each such Trustee shall be trustee of a
      trust or trusts hereunder separate and apart from any trust or trusts hereunder administered by any other such Trustee and that no Trustee shall be responsible for any act or failure to act on the part of any other Trustee hereunder; and upon the
      execution and delivery of such supplemental indenture the resignation or removal of the retiring Trustee shall become effective to the extent provided therein, such retiring Trustee shall with respect to the Securities of that or those series to
      which the appointment of such successor trustee relates have no further responsibility for the exercise of rights and powers or for the performance of the duties and obligations vested in the Trustee under this Indenture, and each such successor
      trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those series to which the appointment of such successor trustee
      relates; but, on request of the Company or any successor trustee, such retiring Trustee shall duly assign, transfer and deliver to such successor trustee, to the extent contemplated by such supplemental indenture, the property and money held by such
      retiring Trustee hereunder with respect to the Securities of that or those series to which the appointment of such successor trustee relates.

    

    

    (c)       Upon request of any such successor trustee, the Company shall execute any and all instruments for more fully and certainly vesting in and confirming
      to such successor trustee all such rights, powers and trusts referred to in paragraph (a) or (b) of this Section, as the case may be.

    

    

    
      35

      
        

    

    (d)      No successor trustee shall accept its appointment unless at the time of such acceptance such successor trustee shall be qualified and eligible under
      this Article.

    

    

    (e)       Upon acceptance of appointment by a successor trustee as provided in this Section, the Company shall send notice of the succession of such trustee
      hereunder to the Securityholders.  If the Company fails to send such notice within ten days after acceptance of appointment by the successor trustee, the successor trustee shall cause such notice to be sent at the expense of the Company.

    

    

    Section 7.12      Merger, Conversion, Consolidation or Succession to Business.

    

    

    Any corporation into which the Trustee may be merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which the Trustee
      shall be a party, or any corporation succeeding to all or substantially all the corporate trust business of the Trustee, including the administration of the trust created by this Indenture, shall be the successor of the Trustee hereunder, provided
      that such corporation shall be qualified under the provisions of Section 7.08 and eligible under the provisions of Section 7.09, without the execution or filing of any paper or any further act on the part of any of the parties hereto, anything herein
      to the contrary notwithstanding.  In case any Securities shall have been authenticated, but not delivered, by the Trustee then in office, any successor by merger, conversion or consolidation to such authenticating Trustee may adopt such
      authentication and deliver the Securities so authenticated with the same effect as if such successor Trustee had itself authenticated such Securities.

    

    

    Section 7.13      Preferential Collection of Claims Against the Company.

    

    

    The Trustee shall comply with Section 311(a) of the Trust Indenture Act, excluding any creditor relationship described in Section 311(b) of the Trust Indenture Act.  A Trustee who has resigned or
      been removed shall be subject to Section 311(a) of the Trust Indenture Act to the extent included therein.

    

    

    Section 7.14      Notice of Default.

    

    

    If any Event of Default occurs and is continuing and if such Event of Default is known to a Responsible Officer of the Trustee, the Trustee shall send to each Securityholder in the manner and to the
      extent provided in Section 313(c) of the Trust Indenture Act notice of the Event of Default within the earlier of 90 days after it occurs and 30 days after it is known to a Responsible Officer of the Trustee or written notice of it is received by the
      Trustee, unless such Event of Default has been cured; provided, however, that, except in the case of a default in the payment of the principal of (or premium, if any) or interest on any Security, the Trustee
      shall be protected in withholding such notice if and so long as the Responsible Officers of the Trustee in good faith determine that the withholding of such notice is in the interest of the Securityholders.

    

    

    
      36

      
        

    

    ARTICLE 8

    

    

    CONCERNING THE SECURITYHOLDERS

    

    

    Section 8.01      Evidence of Action by Securityholders.

    

    

    Whenever in this Indenture it is provided that the holders of a majority or specified percentage in aggregate principal amount of the Securities of a particular series may take any action (including
      the making of any demand or request, the giving of any notice, consent or waiver or the taking of any other action), the fact that at the time of taking any such action the holders of such majority or specified percentage of that series have joined
      therein may be evidenced by any instrument or any number of instruments of similar tenor executed by such holders of Securities of that series in person or by agent or proxy appointed in writing.

    

    

    If the Company shall solicit from the Securityholders of any series any request, demand, authorization, direction, notice, consent, waiver or other action, the Company may, at its option, as
      evidenced by an Officer’s Certificate, fix in advance a record date for such series for the determination of Securityholders entitled to give such request, demand, authorization, direction, notice, consent, waiver or other action, but the Company
      shall have no obligation to do so.  If such a record date is fixed, such request, demand, authorization, direction, notice, consent, waiver or other action may be given before or after the record date, but only the Securityholders of record at the
      close of business on the record date shall be deemed to be Securityholders for the purposes of determining whether Securityholders of the requisite proportion of Outstanding Securities of that series have authorized or agreed or consented to such
      request, demand, authorization, direction, notice, consent, waiver or other action, and for that purpose the Outstanding Securities of that series shall be computed as of the record date; provided, however, that no such authorization, agreement or
      consent by such Securityholders on the record date shall be deemed effective unless it shall become effective pursuant to the provisions of this Indenture not later than six months after the record date.

    

    

    Section 8.02      Proof of Execution by Securityholders.

    

    

    Subject to the provisions of Section 7.01, proof of the execution of any instrument by a Securityholder (such proof will not require notarization) or his or her agent or proxy and proof of the
      holding by any Person of any of the Securities shall be sufficient if made in the following manner:

    

    

    (a)      The fact and date of the execution by any such Person of any instrument may be proved in any reasonable manner acceptable to the Trustee.

    

    

    (b)      The ownership of Securities shall be proved by the Security Register of such Securities or by a certificate of the Security Registrar thereof.

    

    

    The Trustee may require such additional proof of any matter referred to in this Section as it shall deem necessary.

    

    

    
      37

      
        

    

    Section 8.03      Who May be Deemed Owners.

    

    

    Prior to the due presentment for registration of transfer of any Security, the Company, the Trustee, any paying agent and any Security Registrar may deem and treat the Person in whose name such
      Security shall be registered upon the books of the Security Registrar as the absolute owner of such Security (whether or not such Security shall be overdue and notwithstanding any notice of ownership or writing thereon made by anyone other than the
      Security Registrar) for the purpose of receiving payment of or on account of the principal of, premium, if any, and (subject to Section 2.03) interest on such Security and for all other purposes; and neither the Company nor the Trustee nor any paying
      agent nor any Security Registrar shall be affected by any notice to the contrary.

    

    

    Section 8.04      Certain Securities Owned by Company Disregarded.

    

    

    In determining whether the holders of the requisite aggregate principal amount of Securities of a particular series have concurred in any direction, consent or waiver under this Indenture, the
      Securities of that series that are owned by the Company or any other obligor on the Securities of that series or by any Person directly or indirectly controlling or controlled by or under common control with the Company or any other obligor on the
      Securities of that series shall be disregarded and deemed not to be Outstanding for the purpose of any such determination, except that for the purpose of determining whether the Trustee shall be protected in relying on any such direction, consent or
      waiver, only Securities of such series that the Trustee actually knows are so owned shall be so disregarded.  The Securities so owned that have been pledged in good faith may be regarded as Outstanding for the purposes of this Section, if the pledgee
      shall establish to the satisfaction of the Trustee the pledgee’s right so to act with respect to such Securities and that the pledgee is not a Person directly or indirectly controlling or controlled by or under direct or indirect common control with
      the Company or any such other obligor.  In case of a dispute as to such right, any decision by the Trustee taken upon the advice of counsel shall be full protection to the Trustee.

    

    

    Section 8.05      Actions Binding on Future Securityholders.

    

    

    At any time prior to (but not after) the evidencing to the Trustee, as provided in Section 8.01, of the taking of any action by the holders of the majority or percentage in aggregate principal amount
      of the Securities of a particular series specified in this Indenture in connection with such action, any holder of a Security of that series that is shown by the evidence to be included in the Securities the holders of which have consented to such
      action may, by filing written notice with the Trustee, and upon proof of holding as provided in Section 8.02, revoke such action so far as concerns such Security.  Except as aforesaid any such action taken by the holder of any Security shall be
      conclusive and binding upon such holder and upon all future holders and owners of such Security, and of any Security issued in exchange therefor, on registration of transfer thereof or in place thereof, irrespective of whether or not any notation in
      regard thereto is made upon such Security.  Any action taken by the holders of the majority or percentage in aggregate principal amount of the Securities of a particular series specified in this Indenture in connection with such action shall be
      conclusively binding upon the Company, the Trustee and the holders of all the Securities of that series.

    

    

    
      38

      
        

    

    ARTICLE 9

    

    

    SUPPLEMENTAL INDENTURES

    

    

    Section 9.01      Supplemental Indentures Without the Consent of Securityholders.

    

    

    In addition to any supplemental indenture otherwise authorized by this Indenture, the Company and the Trustee may from time to time and at any time enter into an indenture or indentures supplemental
      hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect), without the consent of the Securityholders, for one or more of the following purposes:

    

    

    (a)       to cure any ambiguity, defect, or inconsistency herein or in the Securities of any series;

    

    

    (b)       to comply with Article Ten;

    

    

    (c)        to provide for uncertificated Securities in addition to or in place of certificated Securities;

    

    

    (d)       to add to the covenants, restrictions, conditions or provisions relating to the Company for the benefit of the holders of all or any series of
      Securities (and if such covenants, restrictions, conditions or provisions are to be for the benefit of less than all series of Securities, stating that such covenants, restrictions, conditions or provisions are expressly being included solely for the
      benefit of such series), to make the occurrence, or the occurrence and the continuance, of a default in any such additional covenants, restrictions, conditions or provisions an Event of Default, or to surrender any right or power herein conferred
      upon the Company;

    

    

    (e)      to add to, delete from, or revise the conditions, limitations, and restrictions on the authorized amount, terms, or purposes of issue, authentication,
      and delivery of Securities, as herein set forth;

    

    

    (f)        to make any change that does not adversely affect the rights of any Securityholder in any material respect;

    

    

    (g)       to provide for the issuance of and establish the form and terms and conditions of the Securities of any series as provided in Section 2.01, to
      establish the form of any certifications required to be furnished pursuant to the terms of this Indenture or any series of Securities, or to add to the rights of the holders of any series of Securities;

    

    

    (h)       to evidence and provide for the acceptance of appointment hereunder by a successor trustee; or

    

    

    (i)       to comply with any requirements of the Commission or any successor in connection with the qualification of this Indenture under the Trust Indenture
      Act.

    

    

    
      39

      
        

    

    The Trustee is hereby authorized to join with the Company in the execution of any such supplemental indenture, and to make any further appropriate agreements and stipulations that may be therein
      contained, but the Trustee shall not be obligated to enter into any such supplemental indenture that affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise.

    

    

    Any supplemental indenture authorized by the provisions of this Section may be executed by the Company and the Trustee without the consent of the holders of any of the Securities at the time
      Outstanding, notwithstanding any of the provisions of Section 9.02.

    

    

    Section 9.02      Supplemental Indentures With Consent of Securityholders.

    

    

    With the consent (evidenced as provided in Section 8.01) of the holders of not less than a majority in aggregate principal amount of the Securities of each series affected by such supplemental
      indenture or indentures at the time Outstanding, the Company, when authorized by a Board Resolution, and the Trustee may from time to time and at any time enter into an indenture or indentures supplemental hereto (which shall conform to the
      provisions of the Trust Indenture Act as then in effect) for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner not
      covered by Section 9.01 the rights of the holders of the Securities of such series under this Indenture; provided, however, that no such supplemental indenture shall, without the consent of the holders of each Security then Outstanding and affected
      thereby, (a) extend the fixed maturity of any Securities of any series, or reduce the principal amount thereof, or reduce the rate or extend the time of payment of interest thereon, or reduce any premium payable upon the redemption thereof or (b)
      reduce the aforesaid percentage of Securities, the holders of which are required to consent to any such supplemental indenture.

    

    

    It shall not be necessary for the consent of the Securityholders of any series affected thereby under this Section to approve the particular form of any proposed supplemental indenture, but it shall
      be sufficient if such consent shall approve the substance thereof.

    

    

    Section 9.03      Effect of Supplemental Indentures.

    

    

    Upon the execution of any supplemental indenture pursuant to the provisions of this Article or of Section 10.01, this Indenture shall, with respect to such series, be and be deemed to be modified and
      amended in accordance therewith and the respective rights, limitations of rights, obligations, duties and immunities under this Indenture of the Trustee, the Company and the holders of Securities of the series affected thereby shall thereafter be
      determined, exercised and enforced hereunder subject in all respects to such modifications and amendments, and all the terms and conditions of any such supplemental indenture shall be and be deemed to be part of the terms and conditions of this
      Indenture for any and all purposes.

    

    

    Section 9.04      Securities Affected by Supplemental Indentures.

    

    

    Securities of any series affected by a supplemental indenture, authenticated and delivered after the execution of such supplemental indenture pursuant to the provisions of this Article or of Section
      10.01, may bear a notation in form approved by the Company, provided such form meets the requirements of any securities exchange upon which such series may be listed, as to any matter provided for in such supplemental indenture.  If the Company shall
      so determine, new Securities of that series so modified as to conform, in the opinion of the Board of Directors, to any modification of this Indenture contained in any such supplemental indenture may be prepared by the Company, authenticated by the
      Trustee and delivered in exchange for the Securities of that series then Outstanding.

    

    

    
      40

      
        

    

    Section 9.05      Execution of Supplemental Indentures.

    

    

    Upon the request of the Company, accompanied by its Board Resolutions authorizing the execution of any such supplemental indenture, and upon the filing with the Trustee of evidence of the consent of
      Securityholders required to consent thereto as aforesaid, the Trustee shall join with the Company in the execution of such supplemental indenture unless such supplemental indenture affects the Trustee’s own rights, duties or immunities under this
      Indenture or otherwise, in which case the Trustee may in its discretion but shall not be obligated to enter into such supplemental indenture. The Trustee, subject to the provisions of Section 7.01, shall receive an Officer’s Certificate or an Opinion
      of Counsel as conclusive evidence that any supplemental indenture executed pursuant to this Article is authorized or permitted by the terms of this Article and that all conditions precedent to the execution of the supplemental indenture have been
      complied with; provided, however, that such Officer’s Certificate or Opinion of Counsel need not be provided in connection with the execution of a supplemental indenture that establishes the terms of a series of Securities pursuant to Section 2.01
      hereof.

    

    

    Promptly after the execution by the Company and the Trustee of any supplemental indenture pursuant to the provisions of this Section, the Company shall (or shall direct the Trustee to) send a notice,
      setting forth in general terms the substance of such supplemental indenture, to the Securityholders of all series affected thereby .as their names and addresses appear upon the Security Register. Any failure of the Company to send, or cause the
      sending of, such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture.

    

    

    ARTICLE 10

    

    

    SUCCESSOR ENTITY

    

    

    Section 10.01    Company May Consolidate, Etc.

    

    

    Nothing contained in this Indenture shall prevent any consolidation or merger of the Company with or into any other Person (whether or not affiliated with the Company) or successive consolidations or
      mergers in which the Company or its successor or successors shall be a party or parties, or shall prevent any sale, conveyance, transfer or other disposition of the property of the Company or its successor or successors as an entirety, or
      substantially as an entirety, to any other Person (whether or not affiliated with the Company or its successor or successors); provided, however, the Company hereby covenants and agrees that, upon any such consolidation or merger (in each case, if
      the Company is not the survivor of such transaction) or any such sale, conveyance, transfer or other disposition (other than a sale, conveyance, transfer or other disposition to a Subsidiary of the Company), the due and punctual payment of the
      principal of (premium, if any) and interest on all of the Securities of all series in accordance with the terms of each series, according to their tenor, and the due and punctual performance and observance of all the covenants and conditions of this
      Indenture with respect to each series or established with respect to such series pursuant to Section 2.01 to be kept or performed by the Company shall be expressly assumed, by supplemental indenture (which shall conform to the provisions of the Trust
      Indenture Act, as then in effect) reasonably satisfactory in form to the Trustee executed and delivered to the Trustee by the entity formed by such consolidation, or into which the Company shall have been merged, or by the entity which shall have
      acquired such property.

    

    

    
      41

      
        

    

    Section 10.02    Successor Entity Substituted.

    

    

    (a)       In case of any such consolidation, merger, sale, conveyance, transfer or other disposition and upon the assumption by the successor entity by
      supplemental indenture, executed and delivered to the Trustee and satisfactory in form to the Trustee, of the obligations set forth under Section 10.01 on all of the Securities of all series Outstanding, such successor entity shall succeed to and be
      substituted for the Company with the same effect as if it had been named as the Company herein, and thereupon the predecessor corporation shall be relieved of all obligations and covenants under this Indenture and the Securities.

    

    

    (b)       In case of any such consolidation, merger, sale, conveyance, transfer or other disposition, such changes in phraseology and form (but not in
      substance) may be made in the Securities thereafter to be issued as may be appropriate.

    

    

    (c)        Nothing contained in this Article shall require any action by the Company in the case of a consolidation or merger of any Person into the Company
      where the Company is the survivor of such transaction, or the acquisition by the Company, by purchase or otherwise, of all or any part of the property of any other Person (whether or not affiliated with the Company).

    

    

    ARTICLE 11

    

    

    SATISFACTION AND DISCHARGE

    

    

    Section 11.01    Satisfaction and Discharge of Indenture.

    

    

    If at any time: (a) the Company shall have delivered to the Trustee for cancellation all Securities of a series theretofore authenticated and not delivered to the Trustee for cancellation (other than
      any Securities that shall have been destroyed, lost or stolen and that shall have been replaced or paid as provided in Section 2.07 and Securities for whose payment money or Governmental Obligations have theretofore been deposited in trust or
      segregated and held in trust by the Company and thereupon repaid to the Company or discharged from such trust, as provided in Section 11.05); or (b) all such Securities of a particular series not theretofore delivered to the Trustee for cancellation
      shall have become due and payable, or are by their terms to become due and payable within one year or are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption, and the
      Company shall deposit or cause to be deposited with the Trustee as trust funds the entire amount in moneys or Governmental Obligations or a combination thereof, sufficient in the opinion of a nationally recognized firm of independent public
      accountants expressed in a written certification thereof delivered to the Trustee, to pay at maturity or upon redemption all Securities of that series not theretofore delivered to the Trustee for cancellation, including principal (and premium, if
      any) and interest due or to become due to such date of maturity or date fixed for redemption, as the case may be, and if the Company shall also pay or cause to be paid all other sums payable hereunder with respect to such series by the Company then
      this Indenture shall thereupon cease to be of further effect with respect to such series except for the provisions of Sections 2.03, 2.05, 2.07, 4.01, 4.02, 4.03, 7.10, 11.05 and 13.04, that shall survive until the date of maturity or redemption
      date, as the case may be, and Sections 7.06 and 11.05, that shall survive to such date and thereafter, and the Trustee, on demand of the Company and at the cost and expense of the Company shall execute proper instruments acknowledging satisfaction of
      and discharging this Indenture with respect to such series.

    

    

    
      42

      
        

    

    Section 11.02    Discharge of Obligations.

    

    

    If at any time all such Securities of a particular series not heretofore delivered to the Trustee for cancellation or that have not become due and payable as described in Section 11.01 shall have
      been paid by the Company by depositing irrevocably with the Trustee as trust funds moneys or an amount of Governmental Obligations sufficient to pay at maturity or upon redemption all such Securities of that series not theretofore delivered to the
      Trustee for cancellation, including principal (and premium, if any) and interest due or to become due to such date of maturity or date fixed for redemption, as the case may be, and if the Company shall also pay or cause to be paid all other sums
      payable hereunder by the Company with respect to such series, then after the date such moneys or Governmental Obligations, as the case may be, are deposited with the Trustee the obligations of the Company under this Indenture with respect to such
      series shall cease to be of further effect except for the provisions of Sections 2.03, 2.05, 2.07, 4,01, 4.02, 4,03, 7.06, 7.10, 11.05 and 13.04 hereof that shall survive until such Securities shall mature and be paid.

    

    

    Thereafter, Sections 7.06 and 11.05 shall survive.

    

    

    Section 11.03    Deposited Moneys to be Held in Trust.

    

    

    All moneys or Governmental Obligations deposited with the Trustee pursuant to Sections 11.01 or 11.02 shall be held in trust and shall be available for payment as due, either directly or through any
      paying agent (including the Company acting as its own paying agent), to the holders of the particular series of Securities for the payment or redemption of which such moneys or Governmental Obligations have been deposited with the Trustee.

    

    

    Section 11.04    Payment of Moneys Held by Paying Agents.

    

    

    In connection with the satisfaction and discharge of this Indenture all moneys or Governmental Obligations then held by any paying agent under the provisions of this Indenture shall, upon demand of
      the Company, be paid to the Trustee and thereupon such paying agent shall be released from all further liability with respect to such moneys or Governmental Obligations.

    

    

    
      43

      
        

    

    Section 11.05    Repayment to Company.

    

    

    Any moneys or Governmental Obligations deposited with any paying agent or the Trustee, or then held by the Company, in trust for payment of principal of or premium, if any, or interest on the
      Securities of a particular series that are not applied but remain unclaimed by the holders of such Securities for at least two years after the date upon which the principal of (and premium, if any) or interest on such Securities shall have
      respectively become due and payable, or such other shorter period set forth in applicable escheat or abandoned or unclaimed property law, shall be repaid to the Company on May 31 of each year or upon the Company’s request or (if then held by the
      Company) shall be discharged from such trust; and thereupon the paying agent and the Trustee shall be released from all further liability with respect to such moneys or Governmental Obligations, and the holder of any of the Securities entitled to
      receive such payment shall thereafter, as a general creditor, look only to the Company for the payment thereof.

    

    

    ARTICLE 12

    

    

    IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND

    DIRECTORS

    

    

    Section 12.01    No Recourse.

    

    

    No recourse under or upon any obligation, covenant or agreement of this Indenture, or of any Security, or for any claim based thereon or otherwise in respect thereof, shall be had against any
      incorporator, stockholder, officer or director, past, present or future as such, of the Company or of any predecessor or successor corporation, either directly or through the Company or any such predecessor or successor corporation, whether by virtue
      of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that this Indenture and the obligations issued hereunder are solely corporate obligations, and that no such
      personal liability whatever shall attach to, or is or shall be incurred by, the incorporators, stockholders, officers or directors as such, of the Company or of any predecessor or successor corporation, or any of them, because of the creation of the
      indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities or implied therefrom; and that any and all such personal liability of every name and nature,
      either at common law or in equity or by constitution or statute, of, and any and all such rights and claims against, every such incorporator, stockholder, officer or director as such, because of the creation of the indebtedness hereby authorized, or
      under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities or implied therefrom, are hereby expressly waived and released as a condition of, and as a consideration for, the execution of this
      Indenture and the issuance of such Securities.

    

    

    
      44

      
        

    

    ARTICLE 13

    

    

    MISCELLANEOUS PROVISIONS

    

    

    Section 13.01    Effect on Successors and Assigns.

    

    

    All the covenants, stipulations, promises and agreements in this Indenture made by or on behalf of the Company shall bind its successors and assigns, whether so expressed or not.

    

    

    Section 13.02    Actions by Successor.

    

    

    Any act or proceeding by any provision of this Indenture authorized or required to be done or performed by any board, committee or officer of the Company shall and may be done and performed with like
      force and effect by the corresponding board, committee or officer of any corporation that shall at the time be the lawful successor of the Company.

    

    

    Section 13.03    Surrender of Company Powers.

    

    

    The Company by instrument in writing executed by authority of its Board of Directors and delivered to the Trustee may surrender any of the powers reserved to the Company, and thereupon such power so
      surrendered shall terminate both as to the Company and as to any successor corporation.

    

    

    Section 13.04    Notices.

    

    

    Except as otherwise expressly provided herein, any notice, request or demand that by any provision of this Indenture is required or permitted to be given, made or served by the Trustee, the Security
      Registrar, any paying or other agent under this Indenture or by the holders of Securities or by any other Person pursuant to this Indenture to or on the Company may be given or served by being deposited in first class mail, postage prepaid, addressed
      (until another address is filed in writing by the Company with the Trustee), as follows: Bionano Genomics, Inc., 9540 Towne Centre Drive, Suite 100, San Diego, CA 92121, Attention: Secretary.  Any notice, election, request or demand by the Company or
      any Securityholder or by any other Person pursuant to this Indenture to or upon the Trustee shall be deemed to have been sufficiently given or made, for all purposes, if given or made in writing at the Corporate Trust Office of the Trustee.

    

    

    Section 13.05    Governing Law; Jury Trial Waiver.

    

    

    This Indenture and each Security shall be governed by, and construed in accordance with, the internal laws of the State of New York, except to the extent that the Trust Indenture Act is applicable.

    

    

    EACH PARTY HERETO, AND EACH HOLDER OF A SECURITY BY ACCEPTANCE THEREOF, HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY
      LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS INDENTURE.

    

    

    
      45

      
        

    

    Section 13.06    Treatment of Securities as Debt.

    

    

    It is intended that the Securities will be treated as indebtedness and not as equity for federal income tax purposes.  The provisions of this Indenture shall be interpreted to further this intention.

    

    

    Section 13.07    Certificates and Opinions as to Conditions Precedent.

    

    

    (a)      Upon any application or demand by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company shall
      furnish to the Trustee an Officer’s Certificate stating that all conditions precedent provided for in this Indenture (other than the certificate to be delivered pursuant to Section 13.12) relating to the proposed action have been complied with and,
      if requested, an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent have been complied with, except that in the case of any such application or demand as to which the furnishing of such documents is
      specifically required by any provision of this Indenture relating to such particular application or demand, no additional certificate or opinion need be furnished.

    

    

    (b)      Each certificate or opinion provided for in this Indenture and delivered to the Trustee with respect to compliance with a condition or covenant in
      this Indenture (other than the certificate to be delivered pursuant to Section 13.12 of this Indenture or Section 314(a)(1) of the Trust Indenture Act) shall include (i) a statement that the Person making such certificate or opinion has read such
      covenant or condition; (ii) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; (iii) a statement that, in the opinion of such
      Person, he has made such examination or investigation as is reasonably necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with; and (iv) a statement as to whether or not, in the
      opinion of such Person, such condition or covenant has been complied with.

    

    

    Section 13.08    Payments on Business Days.

    

    

    Except as provided pursuant to Section 2.01 pursuant to a Board Resolution, and set forth in an Officer’s Certificate, or established in one or more indentures supplemental to this Indenture, in any
      case where the date of maturity of interest or principal of any Security or the date of redemption of any Security shall not be a Business Day, then payment of interest or principal (and premium, if any) may be made on the next succeeding Business
      Day with the same force and effect as if made on the nominal date of maturity or redemption, and no interest shall accrue for the period after such nominal date.

    

    

    
      46

      
        

    

    Section 13.09    Conflict with Trust Indenture Act.

    

    

    If and to the extent that any provision of this Indenture limits, qualifies or conflicts with the duties imposed by Section 318(c) of the Trust Indenture Act, such imposed duties shall control.

    

    

    Section 13.10    Counterparts.

    

    

    This Indenture may be executed in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument.  The exchange of
      copies of this Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Indenture as to the parties hereto and may be used in lieu of the original Indenture for all purposes.
      Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes.

    

    

    Section 13.11    Separability.

    

    

    In case any one or more of the provisions contained in this Indenture or in the Securities of any series shall for any reason be held to be invalid, illegal or unenforceable in any respect, such
      invalidity, illegality or unenforceability shall not affect any other provisions of this Indenture or of such Securities, but this Indenture and such Securities shall be construed as if such invalid or illegal or unenforceable provision had never
      been contained herein or therein.

    

    

    Section 13.12    Compliance Certificates.

    

    

    The Company shall deliver to the Trustee, within 120 days after the end of each fiscal year during which any Securities of any series were outstanding, an officer’s certificate stating whether or not
      the signers know of any Event of Default that occurred during such fiscal year.  Such certificate shall contain a certification from the principal executive officer, principal financial officer or principal accounting officer of the Company that a
      review has been conducted of the activities of the Company and the Company’s performance under this Indenture and that the Company has complied with all conditions and covenants under this Indenture.  For purposes of this Section 13.12, such
      compliance shall be determined without regard to any period of grace or requirement of notice provided under this Indenture.  If the officer of the Company signing such certificate has knowledge of such an Event of Default, the certificate shall
      describe any such Event of Default and its status.

    

    

    Section 13.13    U.S.A Patriot Act.

    

    

    The parties hereto acknowledge that in accordance with Section 326 of the U.S.A. Patriot Act, the Trustee, like all financial institutions and in order to help fight the funding of terrorism and
      money laundering, is required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee.  The parties to this Indenture agree that they will provide the
      Trustee with such information as it may request in order for the Trustee to satisfy the requirements of the U.S.A. Patriot Act.

    

    

    
      47

      
        

    

    Section 13.14    Force Majeure.

    

    

    In no event shall the Trustee, the Security Registrar, any paying agent or any other agent under this Indenture be responsible or liable for any failure or delay in the performance of its obligations
      hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or
      acts of God, and interruptions, loss or malfunctions or utilities, communications or computer (software and hardware) services; it being understood that the Trustee, the Security Registrar, any paying agent or any other agent under this Indenture
      shall use reasonable efforts which are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances.

    

    

    Section 13.15     Table of Contents; Headings.

    

    

    The table of contents and headings of the articles and sections of this Indenture have been inserted for convenience of reference only, are not intended to be considered a part hereof, and will not
      modify or restrict any of the terms or provisions hereof.

    

    

    
      48

      
        

    

    In Witness Whereof, the parties hereto have caused this Indenture to be duly executed all as of the day and year first above written.

     

    

    
      	 	
              Bionano Genomics, Inc.

            
	 	 
	 	
              By:

            	

            
	 	
              Name:

            	

            
	 	
              Title:

            	

            
	 	

            
	 	
              [Trustee], as Trustee

            
	 	 
	 	
              By:

            	 
	 	
              Name:

            	 
	 	
              Title:

            	

            

    

    

    
      49

      
        

    

    CROSS-REFERENCE TABLE (1)

    

    

    	
            
              Section of Trust Indenture Act of 1939, as Amended

            

          	 	
            
              Section of Indenture

            

          
	
            310(a)

          	 	
            7.09

          
	
            310(b)

          	 	
            7.08

          
	 	 	
            7.10

          
	
            310(c)

          	 	
            Inapplicable

          
	
            311(a)

          	 	
            7.13

          
	
            311(b)

          	 	
            7.13

          
	
            311(c)

          	 	
            Inapplicable

          
	
            312(a)

          	 	
            5.01

          
	 	 	
            5.02(a)

          
	
            312(b)

          	 	
            5.02(c)

          
	
            312(c)

          	 	
            5.02(c)

          
	
            313(a)

          	 	
            5.04(a)

          
	
            313(b)

          	 	
            5.04(b)

          
	
            313(c)

          	 	
            5.04(a)

          
	

          	 	
            5.04(b)

          
	
            313(d)

          	 	
            5.04(c)

          
	
            314(a)

          	 	
            5.03

          
	 	 	
            13.12

          
	
            314(b)

          	 	
            Inapplicable

          
	
            314(c)

          	 	
            13.07(a)

          
	
            314(d)

          	 	
            Inapplicable

          
	
            314(e)

          	 	
            13.07(b)

          
	
            314(f)

          	 	
            Inapplicable

          
	
            315(a)

          	 	
            7.01(a)

          
	 	 	
            7.01(b)

          
	
            315(b)

          	 	
            7.14

          
	
            315(c)

          	 	
            7.01

          
	
            315(d)

          	 	
            7.01(b)

          
	
            315(e)

          	 	
            6.07

          
	
            316(a)

          	 	
            6.06

          
	 	 	
            8.04

          
	
            316(b)

          	 	
            6.04

          
	
            316(c)

          	 	
            8.01

          
	
            317(a)

          	 	
            6.02

          
	
            317(b)

          	 	
            4.03

          
	
            318(a)

          	 	
            13.09

          

    

    

    
      

    

    

    	(1)	
            This Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions.

          

    

    

    

    

    50

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]